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Abstract 
The spread of bacteria and infections, initially associated with an increased number of 
hospital-acquired infections, has now extended into the community causing severe and 
difficult to diagnose and treat diseases. Additionally, many of those diseases are evoked by 
bacteria that have become resistant to antibiotics. Overcoming the ability of bacteria to 
develop resistance will potentially reduce the burden of these infections on the healthcare 
systems worldwide and prevent thousands of deaths each year.  
At present, there is a great interest in manufacturing antimicrobial materials that would 
provide bacteria-free environment. The nano-scale particles are promising candidates to 
fight bacterial pathogens, since developing of resistance to their action is less likely to occur. 
Nanoparticles (NPs) can be incorporated into polymeric matrices to design a wide variety of 
nanocomposites. Such nano-structures consisting of inorganic and inorganic/organic NPs 
represent a novel class of materials with a broad range of applications. 
This thesis is about the development of antibacterial nano-structured materials aimed at 
preventing the spread of bacteria. To achieve this, two versatile physicochemical and 
biotechnological tools, namely sonochemistry and biocatalysis were innovatively combined. 
Ultrasound irradiation used for the generation of various nano-structures and its combination 
with biocatalysts (enzymes) opens new perspectives in materials processing, here illustrated 
by the production of NPs coated medical textiles, water treatment membranes and chronic 
wound dressings. 
The first part of the thesis aims at the development of antibacterial medical textiles to prevent 
the bacteria transmission and proliferation using two single step approaches for antibacterial 
NPs coating of textiles. In the first approach antibacterial zinc oxide NPs (ZnO NPs) and 
chitosan (CS) were deposited simultaneously on cotton fabric by ultrasound irradiation. The 
obtained hybrid NPs coatings demonstrated durable antibacterial properties after multiple 
washing cycles. Moreover, the presence of biopolymer in the NP hybrids improved the 
biocompatibility of the material in comparison with ZnO NPs coating alone.  
In the second approach, a simultaneous sonochemical/enzymatic process for durable 
antibacterial coating of cotton with ZnO NPs was carried out. The enzymatic treatment 
provides better adhesion of the ZnO NPs and, as a consequence, enhanced coating stability 
during exploitation. Likewise to the antibacterial coatings obtained in the first approach, the 
antibacterial efficiency of these textiles was maintained after multiple intensive laundry 
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regimes used in hospitals. The NPs-coated cotton fabrics inhibited the growth of the most 
medically relevant bacteria species. 
In the second part of the thesis, hybrid antibacterial biopolymer/silver NPs and cork matrices, 
were enzymatically assembled into an antimicrobial material with potential for water 
remediation. Intrinsically antibacterial amino-functional biopolymers, namely CS and 
aminocellulose were used as doping agents to stabilize colloidal dispersions of silver NPs 
(AgNPs), additionally providing the particles with functionalities for covalent immobilization 
on cork to impart durable antibacterial effect. The biopolymers promoted the antibacterial 
performance of the obtained nanocomposites in conditions simulating a real situation in 
constructed wetlands. 
In the last, third part of the thesis, a bioactive nanocomposite hydrogel for wound treatment 
was developed. Sonochemically synthesized epigallocatechin gallate nanospheres (EGCG 
NSs) were incorporated and simultaneously crosslinked enzymatically into a thiolated 
chitosan hydrogel. The potential of the generated EGCG NSs for chronic wound treatment 
was evaluated by assessing its antibacterial properties and inhibitory effect on 
myeloperoxidase and collagenase biomarkers of chronic wound infection. Sustained release 
of the EGCG NSs from the biopolymer matrix was achieved. The latter, coupled with the 
good biocompatibility of the hydrogel suggested its potential for chronic wound 
management. 
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Antibiotic resistance is a growing public health concern worldwide. Each year the number of 
people who acquire infections caused by antibiotic resistant bacteria increases, resulting in 
increased number of deaths. Antibiotics are the most commonly prescribed drugs to treat 
infections caused by bacteria. However, the emergence of new resistant microorganisms 
has accelerated alongside with their misuse and overuse, which contribute to the antibiotic 
resistance around the globe. Direct or indirect contact with a source of infectious pathogens 
e.g. environmental surfaces, healthcare settings, food and water supplies brings about the 
spread and transmission of pathogens. Therefore, an efficient strategy to address the threat 
of antimicrobial resistance should be aimed at: i) the prevention and control of the spread of 
bacteria and infections, and ii) the development of new bactericides to which bacteria cannot 
easily acquire resistance.  
Recent approaches addressing this challenge explore non-traditional antibiotic agents such 
as antimicrobial nanoparticles (NPs) and nanosized carriers for target drug delivery. 
Antimicrobial NPs are found to be effective in inactivating various microorganisms. A variety 
of chemical and physical synthetic routes have been exploited for the NPs synthesis. Among 
them, the use of ultrasound (US) is currently positioned as one of the most powerful tools in 
nano-structured materials synthesis. Moreover, the US irradiation has been successfully 
applied to homogeneously coat the surface of variety of solid substrates, including textiles, 
glass and nylon. It has been demonstrated that the microjets and shock waves produced 
after cavitation collapse are able to drive the NPs at such high velocities towards the solid 
substrate that fusion and strong adherence by physical or chemical interactions with the 
surface occurs during collision. Another promising approach exploiting US is the 
combination of ultrasonic energy and enzymatic treatments as a strategy to boost the 
enzyme activity e.g. to accelerate the mass transfer during some of the textiles’ 
manufacturing steps and thus, shorten the processing time. Both innovative tools (US and 
biocatalysts) could be also employed, alone or in combination, to create antibacterial 
surfaces and devices.  
This thesis aims at designing of nano-functionalized materials able to prevent/reduce the 
bacterial spread. The rationale of the work is the integration of nano- and bio-technological 
approaches with sonochemistry. The innovative combination of antimicrobial NPs, 
biopolymers, enzymes, and sonochemical irradiation is exploited to develop the following 
nano-structured surfaces and devices: i) medical textiles coated with antibacterial metal 
oxide NPs and biopolymer/metal oxide nano-hybrids, ii) antibacterial biopolymer/metal NPs-
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cork composites for water disinfection, and iii) bioactive nanocomposite hydrogels for wound 
treatment.  
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2.1 The global threat of antimicrobial resistance. Hospital-associated 
infections 
 
“Antimicrobial resistance is resistance of a microorganism to an antimicrobial drug that was 
originally effective for treatment of infections caused by it.”1 The antimicrobial resistance 
threatens the effective prevention and treatment of an ever-increasing range of infections 
caused by resistant microorganisms, including bacteria, fungi, viruses and parasites. Those 
microorganisms are able to withstand the attack of antibacterial drugs, antifungals and 
antivirals, so that conventional treatments become ineffective and infections persist, 
increasing the risk of transmission.  
The development of resistant strains is a natural occurrence that happen when resistant 
markers are exchanged between them or when microorganisms replicate themselves 
erroneously. The use and misuse of antimicrobial drugs accelerates the emergence of drug-
resistant strains. Poor infection control practices, inadequate sanitary conditions and 
inappropriate food-handling encourage the further spread of antimicrobial resistance. The 
World Health Organization (WHO) warns that at present the so called “post-antibiotic era”, 
in which common infections and minor injuries can kill, is a very real possibility due to the 
fact that resistance to common bacteria has reached alarming levels worldwide.1 
The mechanisms by which antimicrobials act involve interference with proteins,2 nucleic acid 
synthesis,3 and inhibition of cell-wall synthesis i.e. the peptidoglycan biosynthesis.4,5 
However, bacteria have evolved genetic and biochemical ways of resisting these 
antimicrobial actions and to develop a tolerance to the antimicrobial drugs by several ways:6  
 enzymatic inactivation of the drugs by beta-lactamases, acetylases, adenylases, and 
phosphorylases, 
 limiting the drug access by virtue of membrane characteristics, 
 altering the drug target so that the antimicrobial no longer binds to it,  
 by passing the drug's metabolism, 
 increasing the expression of efflux pumps. 
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Figure 2.1 Bacterial antibiotic resistance mechanisms. Red blocks indicate antibiotics. Yellow 
channels indicate drug entry ports/porins. Mechanisms of bacterial resistance include the alteration 
of drug binding targets (DNA), degradation of antibiotics by enzymatic action, expression of efflux 
pumps on the cell membrane, and alteration or loss of porin/drug entry ports. The latter two 
mechanisms reduce the intracellular concentration and permeability of the drug into the cell.6 
 
The resistance mechanisms develop by enterococci and staphylococci are of particular 
clinical significance as these are among the most frequent causes of infections in the 
healthcare units. The Enterococcus includes some of the most important nosocomial 
multidrug-resistant organisms, and these pathogens usually affect patients who are 
debilitated by other, concurrent illnesses and undergoing prolonged hospitalization.7 The 
surveillance data indicate that the Enterococcus is the third most commonly isolated 
pathogen (12% of all hospital infections), behind only coagulase-negative staphylococcus 
and Staphylococcus aureus (S. aureus).8 The mechanisms underlying antibiotic resistance 
in enterococci may be intrinsic (universally found within the genome of the species) and 
acquired (through mutation of intrinsic genes or horizontal exchange of genetic material 
encoding resistance determinants) and it includes i) intrinsic resistance to β-lactams, 
lincosamides (clindamycin) and streptogramins (quinupristin, dalfopristin) aminoglycosides, 
aztreonam, cephalosporins, imipenem, and trimethoprim-sulfamethoxazole; ii) tolerance to 
all cell-wall-active antimicrobials; and iii) acquired resistance to β-lactams (penicillin), 
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aminoglycosides, glycopeptides (vancomycin), chloramphenicol, erythromycin, tetracycline, 
streptogramins, daptomycin and linezolid.9,10 
The  resistance of staphylococci includes i) beta-lactamase production, ii) secretion of novel 
beta-lactamases, iii) expression of novel penicillin-binding proteins to which penicillins bind 
poorly, and iv) increased production or altered affinity to existing penicillin-binding proteins. 
As aforementioned (Figure 2.1), there are many mechanisms adopted for the development 
of resistance from bacteria and it is of great concern to prevent/reduce the spread of 
antimicrobial resistant pathogens in order to limit the occurrence of hospital acquired 
infections.  
Hospital acquired infections, also called nosocomial infections, can be defined as infections 
that patients develop during the course of receiving healthcare treatment, being not present 
and without evidence of incubation at the time of admission to a healthcare setting. These 
also include infections acquired in the hospital, but appearing after the patients’ discharge 
as well as vocational infections among personnel of the healthcare facility. The terms 
hospital-acquired or nosocomial infections are now replaced by healthcare associated 
infections (HAI) due to the diverse healthcare facilities currently available to patients.1,11  
During hospitalization the patient is exposed to a variety of microorganisms and within hours 
after the admission, the patient's flora begins to acquire the characteristics of the 
surrounding bacterial environment. There are two sources causing HAI - endogenous or 
exogenous. The endogenous sources include body sites that are normally inhabited by 
microorganisms e.g. urinary and gastrointestinal tracts.  While the exogenous sources 
include those that are not part of the patient such as visitors, medical personnel, equipment 
and the healthcare environment.  
The development of clinical disease and thus, the frequency of nosocomial infections, 
depends of many factors such as patients susceptibility and microorganisms characteristics. 
Immunocompromised patients and patients with chronic diseases undergo invasive 
examinations and treatments. Such patients are having increased susceptibility to infections 
with opportunistic pathogens, part of the normal bacterial flora in the human. For example, 
commensal bacteria such as cutaneous coagulase-negative staphylococci cause 
intravascular line infection and intestinal Escherichia coli (E. coli) are the most common 
cause of urinary infection, if the natural host is compromised.12 The HAI infections occur: 
 up to 48 hours after hospital admission,   
 up to 3 days after discharge,  
 up to 30 days after an operation.12 
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The HAI are a major financial issue in the European healthcare system and were recognized 
as a major threat associated with medical care. On average, nosocomial patients stay in the 
hospital 2.5 times longer than patients without infection, hence, adding more than 10 million 
patients in hospitals in Europe per year. The alarming statistics show that 1 in 10 patients is 
affected by HAI which as a consequence leads to a substantial increase in health care costs 
each year.13 Moreover, the HAI are important contributors to morbidity and mortality. Their 
significance as a public health problem increases with increasing economic and human 
impact due to: the increasing numbers and crowding of people, more frequent impaired 
immunity (age, illness, treatments), and most importantly the increasing bacterial resistance 
to antibiotics.12 Among the numerous risk factors for acquiring a nosocomial infection, the 
length of hospital stay is the most important. 
 
 
 
Figure 2.2 Sites of the most common nosocomial infections.12 
 
Bacteria that cause nosocomial infections can be transmitted in several ways: i) from the 
permanent or transient flora of the patient (the bacteria cause infection because of 
transmission to sites outside the natural habitat, damage to tissue (wound) or inappropriate 
antibiotic therapy that allows overgrowth), ii) bacteria transmission from another patient or 
member of the hospital staff (via direct contacts between the patients and contaminated 
staff, via air or objectives when contaminated with patients’ bacteria), and iii) 
microorganisms surviving in the hospital environment (water, food, linen, equipment and 
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supplies used).12 Thus, major efforts of the healthcare organizations nowadays are aimed 
at preventing HAI and other adverse events in order to improve the healthcare delivery. 
 
2.2 Strategies for prevention and control of hospital-associated infections  
The prevention of nosocomial infections requires an integrated and monitored programme 
which includes: i) limiting transmission of organisms and the risk of endogenous infections 
by minimizing invasive procedures, ii) controlling environmental risks for infection, and iii) 
promoting optimal antimicrobial use and surveillance of infections.12 It was shown that the 
implementation of the infection control programmes could reduce the occurrence of 
nosocomial infections by 32 %.14 Thus, the attention to the preventive strategies may 
significantly reduce disease transmission rates. Frequent hand washing remains the single 
most important intervention in infection control. The use of gloves, gowns, and masks 
together with the employment of adequate sterilization and disinfection practices have a role 
in preventing infections.15  
Despite the completion of the previously stated prevention strategies, the problem of 
infections related to medical implants and devices persists as their role in the disease 
transmission remains undefined. The virulent microorganisms can readily colonize surfaces 
of materials, such as white coats, bed sheets, stethoscopes and catheters among others.15 
Moreover, bacteria can grow in colonies which encapsulate itself with a protective 
extracellular polymeric matrix forming biofilms. The biofilm structure becomes much harder 
to combat than circulating bacteria due to the intrinsic resistance of these structures to 
antimicrobial agents and host defense mechanisms.16 Thus, there is a strong need to 
mitigate bacterial colonization by imparting antibacterial surface properties or by equipping 
the medical surfaces with features that prevent bacterial attachment.  
Several surface modification approaches aimed at introducing surface-mediated 
antibacterial properties are focused on improving the currently marketed materials or on 
designing of new ones (Figure 2.3). 
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Figure 2.3 Surface modification approaches in medical devices aimed at obtaining antibacterial properties (adapted from17). 
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Important efforts have been directed at designing surfaces that release antibacterial agents. 
In this line, polymers and polymer coatings present a potentially interesting approach when 
controlled drug release of organic or inorganic antimicrobial actives is envisaged. Drug 
release from a matrix has intrinsic disadvantages involving the duration and effectiveness 
of the antibacterial action, since they are limited by drug loading and release kinetics. This 
issue, however, can be overcome by applying strategies to control the release of actives 
from the matrices. Such approaches include the covalent immobilization of the active 
molecules on the surface or their loading into polymer matrices (which allows their controlled 
release as the polymer degrades). The designing of inorganic (or hybrid organic-inorganic) 
coatings, in which both an antibacterial activity (from the surface) and antimicrobial 
compound release are possible is another promising strategy.17 
The development of antimicrobial biomaterials and coatings based on nanosized particles 
is of great interest in the fields of bionanotechnology and applied nanomaterials due to their 
extraordinary size-dependent physical and chemical properties. At present, the 
nanomaterials are rapidly being commercialized and have become indispensable in many 
areas of human activity such as biology and medicine.18  
 
2.3 Antibacterial nanoparticles 
Nanoparticles (NPs) are microscopic particles having at least one dimension in the order of 
100th of nm or less. However, in the literature often the term “nano” is used for any particles 
in the size range 1–1,000 nm especially when referring to organic structures design for e.g. 
drug delivery applications or structures composed from more than one type of molecules.19,20 
The nano-structures are consider as a bridge between bulk materials and atomic or 
molecular structures. The bulk material usually have constant physical properties regardless 
of its size, but at the nano-scale often this is not the case.  
In the fields of science and technology the nanomaterial can be used for a wide variety of 
applications since they possess unique and beneficial chemical, physical, and mechanical 
properties. The application of different nanoscale materials is getting importance in areas 
such as electronic storage systems,21 civil engineering,22 chemistry,23 biomedicine and 
molecular biology,24,25 vehicles for gene and drug delivery,26,27 biomagnetic separation,28 
agro-food industry,29 textile engineering,30 and semiconductor physics31, providing novel 
technological advances. Nowadays, a close attention receives the usage of antibacterial 
nanomaterials, such as chitosan (CS) NPs, proteins, metal-containing NPs e.g. metal and 
 14 
 
metal oxides (MeO) NPs etc. Some of these nano-scaled particles act with multiple 
simultaneous mechanisms against microbes (Figure 2.4) which makes the development of 
resistance to these NPs unlikely, because multiple simultaneous gene mutations in the same 
bacterial cell would be required for that resistance to develop.32 The antimicrobial NPs can 
be used effectively by coating them on the surfaces that require antimicrobial functions, for 
instance, on medical devices, textiles and water treatment filters.33 
 
 
Figure 2.4 Multiple mechanisms of antimicrobial action of, chitosan-containing NPs (chitosan NPs), 
silver-containing NPs (AgNPs), zinc oxide-containing NPs (ZnO NPs), copper-containing NPs, and 
magnesium-containing NPs; ROS refers to reactive oxygen species (adapted from32). 
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2.3.1 Synthesis of nanoparticles. Sonochemistry - a versatile tool for 
nanoparticles synthesis and antimicrobial nano-functionalization of 
surfaces 
Different physical and chemical processes are currently used to synthesize metal NPs, with 
desired size, size distribution and morphology/shape. While some methods are bottoms up 
(synthesis), some are called top down ("milling"). Top down methods involve braking the 
larger materials (bulk or micro structures) into NPs, while bottom up methods start form 
homogeneous solution or gas to build up the nano-structure (particle, layer, wire etc.). The 
synthesis methods include liquid and gas phase processes such as micro-emulsion, reverse 
micelle process, novel spray methods and sol-gel assisted in-situ techniques. 
Some of the most common techniques used to prepare biodegradable NPs (nanospheres 
(NSs) and nanocapsules (NCs)) include coacervation and phase separation, emulsification 
diffusion, solvent displacement and solvent evaporation, sol-gel encapsulation, supercritical 
fluid technology, spray drying and spray congealing.34 However, the majority of the synthesis 
routes for generation of polymeric nanoscale biomedical materials are based on 
emulsification techniques, and are achieved either directly from a macromolecule, or through 
a polymerization reaction during the preparation.35,36 Selection of an appropriate route 
depends on different factors including the particle size, their thermal, chemical and 
physiological stability, and the requirement of an organic solvent and surfactants in the 
reaction. The latter two are being directly associated with the biocompatibility of the final 
product. However, whenever referring to the industry, the main requirements to the NPs 
synthesis process are to be low-cost, environmentally friendly and to be suitable for both 
continuous operation and a high production rate. 
Sonochemistry is a research field in which due to the application of powerful ultrasound (US) 
radiation molecules undergo a chemical reaction. The US irradiation of liquids (20 KHz–10 
MHz) creates conditions important for the improvement of the stoichiometric and catalytic 
chemical reactions by increasing the reactivity, in some cases, nearly by a million-fold. The 
greatest advances in sonochemistry, however, reside in the production of new materials with 
unusual properties. The synthesis capacity of US comes from the acoustic cavitation 
phenomenon, which consists of the formation, growth and the implosive collapse of bubbles 
in a liquid.37 The dynamics of i) cavity growth, through the diffusion of solute vapor into the 
volume of bubble, and ii) collapse, which occurs when the bubble size reaches its maximum, 
are highly dependent on the local environment and are different in homogeneous liquids and 
near the liquid-solid interface. The implosions of cavities inside which gases and vapors are 
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compressed, generate intense heat that raises the temperature of the liquid surrounding the 
cavity and creates local hot spots.38 It is claimed that upon the collapse of bubbles, 
temperatures of nearly 5000 °C and local pressures as high as 500 atmospheres are 
obtained (Figure 2.5A). Since the collapse of bubbles occurs in less than nanoseconds, the 
heating and cooling rates during cavitation are greater than 109 K/s.39  
In general, no chemical reactions happen when US irradiation is applied to solid and solid-
gas systems as the cavitation phenomenon takes place only in liquids. Thus, the chemical 
effects of US fall into three areas: i) homogeneous sonochemistry of liquids, ii) 
heterogeneous sonochemistry of liquid-liquid or liquid-solid systems, and iii) sonocatalysis 
(initiation of a catalytic reaction by irradiation with US).39 The source of homogeneous 
sonochemistry is the localized hot spot, while related phenomena occur with cavitation in 
liquid-solid systems. There are two important aspects - microjets and shock waves - derived 
from cavitation observed nearby surfaces. The cavitation and the shock waves, created by 
US can accelerate solid particles to very high velocities, as the non-spherical collapse of the 
cavities drives high speed microjets of liquid directed towards the surface (Figure 2.5B).  
 
 
 
 
 
 
Figure 2.5 A) Bubble formation, growth and subsequent collapse over several acoustic cycles. A 
bubble oscillates in phase with the applied sound wave, contracting during compression and 
expanding during rarefactions,40 B) Collapsing bubbles near a surface experience non-uniformities in 
their surroundings that results in the formation of high-velocity microjets.41 
 
These extreme conditions cause the rupture of chemical bonds and enhance mass transport 
and thus, cause changes in the surface morphology, reactivity and composition. In the 
process of formation of nanomaterials, their solid state is determined by the high cooling 
A 
B 
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rates coupled with the type of precursors used. In the case, when volatile precursors are 
used, gas phase reactions are predominant and the formed NPs are amorphous.42 On the 
other hand, when for the synthesis of NPs the precursor is a non-volatile compound, the 
reaction occurs in the liquid phase and in this case the products formed could be 
nanoamorphous or nanocrystalline.38 The latter depends upon the temperature of the ring 
region, where the reactions take place. In the former case, the volatile precursor (e.g. a 
volatile organometallic compound) will produce free metal atoms generated by bond 
dissociation due to the high temperatures created during bubble collapse. These atoms can 
be injected into the liquid phase and nucleate to form NPs or other nano-structured materials 
if appropriate templates or stabilizers are present in the solution. Nonvolatile precursors may 
still undergo sonochemical reactions, even outside of the collapsing bubbles by undergoing 
reactions with radicals or other high energy species produced from the sonolysis of vapor 
molecules inside the collapsing bubbles that then diffuse into the liquid phase to initiate a 
series of reactions (e.g. reduction of metal cations, Figure 2.6).43 
 
 
 
 
Figure 2.6 Primary sonochemistry and secondary sonochemistry for preparation of nanomaterials. 
An example of primary sonochemistry is the generation of metal atoms from sonolysis of weak metal–
carbon bonds from volatile organometallic compounds inside the collapsing bubble that then diffuse 
into the bulk liquid to form functional nanomaterials. Secondary sonochemical products may arise 
from chemically active species (e.g., organic radicals from sonolysis of vapour) that are formed inside 
the bubble, but then diffuse into the liquid phase and subsequently react with solution precursors to 
form a variety of nano-structured materials.43 
 
The importance of sonochemistry in the fields of material science and nanotechnology rises 
up through its advantages for i) preparation of amorphous NPs, ii) formation of 
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proteinaceous and polymer micro- and nano-particles, iii) insertion of nanomaterials into 
mesoporous materials, and iv) deposition of NPs on metal, ceramic and polymeric surfaces. 
The advantages of US over the conventional methods for NPs preparation include shorter 
reaction times, milder reaction conditions, higher yields, improved selectivity and clean 
reactions.44–47 Moreover, sonochemical routes often do not employ any binding agents or 
stabilizers. For instance, Gedanken and coworkers have readily synthesized by US 
irradiation different metallic NPs and core-shells with encapsulated metal without using 
coupling agents.48–51 
The extreme conditions attained during bubble collapse (localized hotspot through adiabatic 
compression or shock wave formation within the gas phase) have been exploited to 
decompose chemical bonds and generate a variety of nano-structured materials such as 
metal,52,53 MeO/metal hydroxides54–62 metal sulfides,63 metal nitrides,64 metal carbide 
NPs65,66 bimetallic NPs,67–71 semiconductor NPs,72,73 metal-polymer composites,74,75 ceramic 
materials69,76 and others.62,77 For the generation of these structures acetate,53,58,60,73,78 
aqueous metal salts solution,61,72,79 ammonia complexes57,63 and organometallic 
precursors55,65,77,80,81 have been used. 
The sonochemical synthesis of nanostructured materials is also extremely versatile as 
various forms of nanophase materials can be generated simply by changing the reaction 
conditions, e.g. temperature, concentration of precursors, sonication power and 
time.44,57,60,69,82–84 Nanowires,85–87 nanorings,52,88,89 nanotubes,72,88 nanorods,88,90–92 
nanoplates,52,74 nested inorganic fullerenes93, spheres,63,94 nanocylinders95 and many others 
structures, such as whiskers-like,72,96 flower-like94,97 and wormhole-like98 are among the 
shapes of sonochemical products. For instance, by controlling the process parameters zinc 
oxide (ZnO) nanostructures with different morphology were synthesized by Jung et al.94 ZnO 
nanorods and nanocups were obtained by changing the concentration of the precursors 
(zinc nitrate hexahydrate and hexa-methylenetetramine) and sonication time, while triethyl 
citrate was used as an additional chemical to synthesize ZnO nanodisks. For the synthesis 
of ZnO nanoflowers and NSs, zinc acetate dihydrate and ammonia–water were used as zinc 
cation and hydroxide anion precursors, respectively. In this case, for the synthesis of ZnO 
NSs triethyl citrate was added to the above mixture. Recently, US-assisted anionic 
biosurfactants (rhamnolipids and surfactin)-template route was developed to synthesise α-
HH nano-CaSO4.44 Control over the crystal polymorph, size and shape of nano-CaSO4 was 
achieved by adjusting the molar ratio of (NH4)2SO4/CaCl2 and the mass ratios of 
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rhamnolipid/H2O, surfactin/H2O and rhamnolipid/surfactin. It was observed that with 
increasing the biosurfactants/H2O ratios, crystal length and aspect ratio decreased whereas 
by increase the surfactin ratio, the crystal morphology gradually changes from long rods to 
hexagonal plate and then to plate-like structures. The preferential adsorption of rhamnolipid 
on the side facets and surfactin on the top facets contributes to the morphology control. In 
this study, the US approach was found to be superior to conventional in situ deposition 
technique used for the synthesis of nano-CaSO4 in terms of energy efficiency, processing 
time, yield and crystallization habit (crystal shape, morphology and l/w aspect ratio).  
Surface modification has been recognized as one of the most advanced and intriguing 
methods to build tailored nanomaterials. One of the benefits of coating NPs on 2D and 3D 
surfaces is the avoidance of the release of the NPs to the environment. The coated 
nanomaterials provide a very high surface area and possess chemical and physical 
properties that are distinct from those of the individual components. Moreover, the 
sonochemistry is a method that enables to simultaneously produce NPs and deposit them 
on the substrates in one single step. Gedanken and co-workers have defined two routes for 
the NPs deposition on substrates under US: i) ‘‘throwing stones’’ mode of deposition99 and 
ii) in situ mode of deposition.100,101 In the “throwing stones” mode of deposition, the 
substrates are coated with preliminarily synthesized NPs or commercial NPs, while in the in 
situ mode the substrates are coated with NPs that were directly synthesized during the 
sonochemical reaction. An additional route for the deposition of NPs very similar to the in 
situ coating method was found for the sonication of aqueous solutions of either inorganic102 
or organic compounds.103 For instance, it was found that the sonication of aqueous solutions 
of inorganic compounds (NaCl, CuSO4, KI) resulted in the formation of salt NPs, but not 
metal or MeO NPs (as in the case of in situ method).102 
The sonochemical coating is performed by the “bombardment” of 2D and 3D solid surfaces 
(ceramic, polymeric, glass, metal, textiles and paper) by liquid microjets carrying NPs. These 
microjets are formed when the acoustic bubble collapses near a solid surface. In the one-
step sono-process the newly formed NPs (or commercial one) are embedded physically into 
the solid surface by the microjets moving at speeds >200 m/sec. This process produces a 
uniform homogenous and stable coating of NPs on surfaces with different functional groups. 
Various metal NPs were deposited with the aid of US on different organic and inorganic 
supports, such as polystyrene104, poly(methyl methacrylate),105,106 silica,107–111 and 
alumina.112 For example, a nanocomposite from silver/nylon 6,6 has been produced from an 
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aqueous solution of silver nitrate (AgNO3) in the presence of ammonia and ethylene glycol 
by an US-assisted reduction method. Larger NPs (50 – 100 nm) were finely dispersed onto 
the polymer surface, while smaller NPs (20 nm) have penetrated the surface and distributed 
inside the polymer grains. The obtained nanocomposites were stable to washing and were 
used as a master batch for the production of nylon yarns by melting and spinning processes. 
The produced nylon fibers have demonstrated good antibacterial performance towards 
Gram-positive S. aureus and Gram-negative Pseudomonas aeruginosa (P. aeruginosa) 
bacteria.113 Zinc oxide NPs (ZnO NPs) were deposited on a glass slides by sonochemical 
irradiation of the Zn2+ ions precursor in a water–ethanol mixture.114 The leaching of NPs was 
tested in water, or ethanol and/or acetone solutions. The results demonstrated that the 
sonochemically deposited ZnO NPs are strongly anchored to the glass, as no NPs were 
detected in the leaching solutions after 7 days of incubation. Recently, Kiel et al. reported 
on sonochemical preparation of salt NPs from an aqueous solution of NaCl, CuSO4 and KI 
and simultaneous deposition on glass microscope slide, a parylene-coated glass slide, or a 
silicon wafer.102 It was found that the increasing of the initial ions concentration and US 
treatment time, lead to enlarged NPs and appearance of aggregates on the substrate 
surfaces. 
The application of US to produce high performance nanocomposite coatings on steel was 
also demonstrated by several research groups. For example, Zn–Ni–Al2O3 nanocomposite 
coatings on low carbon steel were fabricated using eletrodeposition technique with the aid 
of US by Zheng and co-workers.115 It was shown that the US vibration significantly improved 
the uniform dispersion of nano-alumina particles in the matrix and increased the nano-
alumina content incorporated in the Zn–Ni–Al2O3 nanocomposite coating. Further, the 
anticorrosion properties and the hardness of Zn–Ni–Al2O3 composite coatings were 
improved significantly as compared to the Zn–Ni alloy, which was related to the nano-
aluminia content and dispersion in the matrix. Soloviev and co-workers have generated 
silver NPs (AgNPs) by reduction of AgNO3 by ethylene glycol and simultaneously coated 
them on stainless steel plate.116 They found that the adherence of the particles on the steel 
substrate is not as good as in the case when soft substrates are used. Moreover, by 
increasing the distance between the substrate and the sonochemical horn the coating was 
found to be unstable and easily washed. The metal flat surfaces usually provide fewer 
possibilities for direct functionalization especially without any additives as compared to 
polymeric materials. This leads to lower coating stability and thus, decreased life-time at use 
of the product. 
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The sonochemical process enables also to coat the inner walls of hollow tubing e.g. AgNPs 
were deposited in a one-step US process on tubing made of rubber, PVC, Teflon and 
polyethylene.117 In another approach enzyme NPs of α-amylase were also in situ generated 
and immobilized onto polyethylene films via high-intensity US.118 
Sonochemical methods have also been applied to solve the stability problem of magnetic 
NPs119,120 through their sonochemical coating with polymers or deposition on surfaces. The 
US irradiation was used as a way to prevent the agglomeration of the magnetite particles 
and accelerate the hydrolysis and condensation of tetraethyl orthosilicate.121,122 The method 
resulted in homogeneously coated NPs due to the improved mass transfer of silica sols to 
NPs surface. It was found that the thickness of the silica layer over the NPs could be easily 
controlled by the sonication time.121 The challenges in synthesis of iron air-stable structures 
were also overcome by sonochemistry. Air-stable iron NPs were synthesized and deposited 
on the surface of carbon spherules by US.49 The process consist of sonochemical 
decomposition of Fe(CO)5 in diphenylmethane. This approach was previously applied by 
Nikitenko and co-workers, who synthesized highly magnetic, air-stable iron-iron carbide NPs 
by using power US.123 Their finding showed that during the sonolysis of neat 
diphenylmethane a polymer-like solid product is formed, which coats the surface of iron NPs 
formed simultaneously from Fe(CO)5. Recently, the synthesis of magnetically recyclable 
thin-layer MnO2 nanosheet-coated Fe3O4 nanocomposites with photocatalytic properties by 
combined hydrothermal/US approach was also reported.124 
 
2.3.2 Metal and metal oxide nanoparticles 
Because of their biocidal activity, metals have been widely used for centuries as 
antimicrobial agents. Nano-metal and metal based compounds such oxides or salts are 
claimed to be more biocidal (at very low concentrations) than many conventional antibiotics, 
which utilization at high concentrations can induce adverse effects and toxicity to human 
cells.125,126 Moreover, the use of antibacterial NPs is also among the most promising 
strategies to overcome the microbial drug resistance.127 The generally accepted mechanism 
of metallic NPs antibacterial action involves generation of reactive oxygen species (ROS) 
including hydrogen peroxide (H2O2), OH¯ (hydroxyl radicals), and O−22  (peroxide), followed 
by the disruption of the bacterial cell membrane (Figure 2.4).126,128–131 These killing 
mechanisms are usually less prone for the development of antimicrobial resistance.33 
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However, while for some of the metallic NPs the mechanism of antibacterial activity is widely 
investigated and clarified, for others still remains a subject of debate. The bactericidal effect 
of those nanosystems depends on several parameters such as NP’s size, stability and 
concentration.  
Many studies indicate that smaller NPs have better antibacterial performance than the 
bigger ones. Morones et al. have reported on the AgNPs size effect against Gram-negative 
bacteria.132 They investigated particles in the range of 1–100 nm and had found that the NPs 
in a direct interaction with the bacteria preferentially had a diameter of ~1–10 nm. 
Another factor that could play a role for the antibacterial properties of the NPs is their shape. 
For instance, the shape dependent antibacterial performance against Gram-positive 
Streptococcus iniae and Streptococcus parauberis and Gram-negative E. coli and Vibrio 
anguillarum bacteria was observed for the copper oxide NPs (CuO NPs).133 The tested NPs 
shapes included surface morphologies such as rice grain-like, needle-like and plate-
like.  Among these differently shaped CuO nanomaterials, the plate-like CuO displayed 
better antibacterial activity than grain or needle shaped nano-CuO. 
Recently, Perelshtein and co-authors have reported that the antibacterial properties of metal 
oxide NPs (MeO NPs), namely ZnO and CuO, depends on their crystalline structure, 
whereas the presence of more defects and less organized structure leads to higher 
toxicity.134 Their study compared the activity of commercial and sonochemically produced 
NPs. A significant increase in the production of ROS was found in the more defective, 
sonochemically prepared metal nanooxides, as compared to the commercial ones with the 
same particle size range. 
The bactericidal efficiency of the metallic NPs may be also affected by the type of 
microorganism i.e. to be strain-specific. For instance, E. coli, S. aureus and Bacillus subtilis 
(B. subtilis) bacteria strains susceptibility to silver and copper NPs (CuNPs) was 
studied.135,136 The E. coli and S. aureus were more susceptible to the effect of the AgNPs 
compared to the CuNPs, while B. subtilis depicted the highest sensitivity to NPs compared 
to the other strains and was more adversely affected by the CuNPs.135 The greater biocidal 
efficiency of AgNPs for E.coli (Gram-negative) than to S. aureus (Gram-positive) was 
attributed to the difference in cell wall structure between Gram-negative and Gram-positive 
microorganisms.137 
The antibacterial properties of metal NPs were largely studied against human pathogenic 
bacteria such as P. aeruginosa, E. coli, S. aureus, Klebsiella pneumoniae and the antibiotic 
resistant bacteria as methicillin-resistant Staphylococcus aureus (MRSA). For instance, 
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copper,138 CuO,131,139 zinc140,141 and ZnO,142 titanium143 and TiO2,144 MgO,145 gold,146 
alginate147 and silver140,143,146 are among the NPs that antibacterial effectiveness against 
bacteria, viruses and other eukaryotic micro-organisms have been proved.  
Silver and zinc NPs supported on various suitable materials, such as carbon, polyurethane 
foam,148 polymers and sepiolite149 have been effectively used for biological applications due 
to their bactericidal properties. In the medicine, materials comprising nano-silver are used 
also to prevent bacteria colonization on catheters,150 contact lenses,151 dental materials,152 
medical instruments,153 and human skin.154 
The application of AgNPs in the medical and pharmaceutical fields is widely exploited due 
to their high thermal stability, low volatility and low toxicity to human cells. The AgNPs are 
among the approved by the U.S. Food and Drug Administration nano-devices for 
antibacterial wound dressings. Silver-containing materials can be also employed to eliminate 
microorganisms on textile fabrics,155,156 or they can be used for water treatment purposes.157 
In fact, by far silver is the most widely used antimicrobial material incorporated in the form 
of nano-silver in functional textiles. For example, powdered AgNPs were prepared using 
alkali dissolved starch as reducing and stabilizing agent followed by applying these particles 
to cotton fabrics. The developed material showed potential as wound dressing material as it 
demonstrated good antibacterial and anti-inflammatory properties.158 In another approach, 
AgNPs impregnated paper as point-of-use device for microbial purification of drinking water 
was designed. The embedded in the blotter paper NPs release was minimal, with values 
under the WHO limit of 0.1 ppm for silver in drinking water.159 
Composite metal-metal NPs have been also applied in biomedical areas as antibacterial 
agents as well as for bioseparations, targeted drug delivery and magnetic resonance 
imaging. The combined use of silica NPs with the other biocidal metals such as silver has 
been extensively studied in the recent years. For example, the production of novel 
antimicrobial silver–silica nanocomposite material was reported.160 The results revealed that 
the nanocomposite have better antimicrobial effect against a wide range of microorganisms 
compared to conventional materials, such as silver nitrate and silver zeolite. In another 
study, silica nanowire substrates decorated with Ag- or CuNPs have demonstrated strong 
antibacterial activity against E. coli. However, while silver decorated silica nanowires were 
found to be biocompatible with human lung adenocarcinoma epithelial cell line A549, the 
copper decorated silica nanowires showed high cytotoxicity.161 In another study, the 
antibacterial activity of nanostructured ZnMgO was compared to its pure nano-ZnO and 
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nano-MgO counterparts. Among the three oxides, the ZnO nanocrystals were found to be 
the most effective antibacterials against both Gram-positive (B. subtilis) and Gram-negative 
(E. coli) tested bacteria. The magnesium oxide NPs (MgO NPs) revealed moderate activity, 
whereas the ZnMgO NPs indicated high specific antibacterial activity to B.subtilis. It was 
shown that the ZnO NPs alone were toxic when applied to human HeLa cells, while MgO 
NPs and the mixed oxide did not induce any cell damage, which suggested that nano-
structured ZnMgO could be used as a safe new therapeutic for bacterial infections.162 
However, the studies to evaluate the biological toxicity of nano-metals still continue, since 
hazard issues should be considered when using MeO antimicrobials as a therapy in 
humans.163–165 Optimizing the metal concentrations to non-hazardous levels without 
affecting their functional properties would be a way to diminish the cytotoxic effect of these 
systems. This target is achievable by combining metal NPs with antimicrobial polymers that 
enhance their stability and efficacy. Thus, a hybrid nanomaterial comprising metal NPs and 
antimicrobial biopolymer is expected to exhibit low toxicity coupled to high antimicrobial 
efficiency even in low particles concentration. Such composites have already been used as 
drug delivery devices and antibacterial coatings.166 For example, complexing metal NPs with 
chitosan (CS), a biopolymer with intrinsic antimicrobial properties,167 resulted in enhanced 
antibacterial performance,168 homogeneous NPs distribution on solid surfaces and improved 
cytotoxicity profiles due to the low dissolution rates of the metal from such complexes.168,169  
 
2.3.3 Hybrid polymer/metal nanoparticles 
Inorganic NPs are frequently engineered with an organic surface coating to improve their 
physicochemical properties. Metal NPs are used due to both - their enhanced antimicrobial 
behavior as compared with traditional materials and their capacity to be embedded into 
polymer matrices. However, there lies a main question in preparing metal based NPs stable 
enough during their exploitation or storage. Owing to the decreased particles’ size and the 
increased surface area all nano-structured materials possess an excess surface energy in 
comparison with the bulk counterparts, and thus are thermodynamically unstable or 
metastable. For example, irreversible aggregation is observed for aqueous suspensions  of  
unprotected  silver  and  gold  particles.170 Thus, one of the great challenges is to overcome 
the surface energy and to prevent the NPs aggregation which is driven by reduction of 
overall surface energy (in order to reach thermodynamic stability i.e. lowest energy state). 
Traditionally the aggregation is overcome through the spontaneous adsorption on the 
particle surface of different coating materials or by involving of stabilization process i.e. 
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reducing of the metal ions in presence of polymers, hydrogels and surfactants. Whenever 
the surface of the NPs is modified by molecules or coated with a thin layer of other materials 
(with different constituents), they show enhanced properties compared to the non-
functionalized uncoated particles.171 However, it is worthy to mention that even NPs with 
high colloidal stability can change their physicochemical properties in vivo. The stability in a 
mammalian organism remains unknown as following internalization by cells, the NPs are 
typically localized inside highly acidic endosomes and/or lysosomes and the polymer shell 
could be degraded upon the activities of different enzymes.172  
Various commercially available polymers including poly(methacrylic acid),173 poly(maleic 
anhydride alt-1-tetradecene),174 poly(acrylic acid),175,176 poly(ethylene glycol)177 and poly-
(allylamine hydrochloride)176 have been used as coating materials on the surface of metallic 
NPs. Introducing polymers with specific characteristics to the surface of the NPs is also a 
strategy for developing of novel functional hybrid nanomaterials due to the polymer’s 
physicochemical properties (solubility, hydrophilicity and hydrophobicity).178  
While some of the polymers are being applied only as stabilizers, another are preferred due 
to their specific properties e.g. desired functional groups. For example, the polymeric shells 
containing functionalities such as phenyl, ammonium, or thiol pending groups (derived from 
poly(dimethylpropargylamonium chloride), or poly(phenylacetylene-co-allylmercaptan), 
respectively) have been used to tune hydrophilic and hydrophobic properties and solubility 
of the target core shell systems based on noble metal NPs (gold NPs, AgNPs, platinum 
NPs).179  
The designing of hybrid nanocomposites comprising of natural polymers (biopolymers) with 
antimicrobial activity and inherent biodegradability and biocompatibility (e.g. chitosans)180,181  
and metal NPs is highly appealing because of the individual antibacterial activity of both 
components. For instance, CS-Ag NPs bionanocomposites have shown to possess higher 
antibacterial activity than any of the components acting alone against Gram-negative E. 
coli182 and Gram-positive S. aureus183 bacteria.  Biopolymers bearing amino moieties are 
intrinsically antimicrobial and impart positive charge onto the metal surface to lower the 
particles aggregation over a wide pH range, thereby extending the shelf life of these 
systems.184,185 Moreover, the inclusion of amino functionalities brings about reactivity to the 
otherwise inert metal NPs, necessary for permanent immobilization of the hybrid biopolymer-
metal NPs onto different surfaces. Covalent immobilization on solid substrates is not only 
employed to facilitate the recovery, but also the NPs reuse.184,186 
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Furthermore, naked metal based NPs are reported to be toxic to human cells and to 
potentially induce oxidative stress processes in the body.187,188 It was demonstrated that the 
surface coating of those NPs with a biopolymer shell is an effective way to improve/enhance 
their biocompatibility.189,190 The latter makes them suitable for various biological and 
biomedical applications. For example, recent studies have focused on dual-action NPs for 
inactivation of pathogens under magnetic hyperthermia. Antibacterial NPs for magnetic 
hyperthermia coated with shells of oleic acid, polyethyleneimine and polyethyleneimine-
methyl cellulose have been synthesized and their antibacterial and antibiofilm properties 
were evaluated against E. coli and S. aureus bacteria.191 Such nano-structures have shown 
potential against antibiotic resistant strains like MRSA.192 The antibacterial properties of 
hyperthermia agents appeared to be highly desired as this would decrease the bacterial 
infections co-locallized with cancer.192,193  
 
2.3.4 Nanoparticles as drug delivery system 
One of the most promising applications of nanomedicine technology is the development of 
nanoparticulate drug delivery systems for diseases monitoring, control, treatment, and 
diagnosis. Among all investigated in this field nano-scaled structures probably the most 
promising candidates are the biodegradable NPs. The main advantages of such particles 
are their biocompatibility and ability to deliver effectively drug to a target site and as a 
consequence, to increase the therapeutic benefit while minimizing side effects. Those nano-
structures are aimed to provide the stability of the drug and are characterized with specific 
control release properties.  
In general, the nano-scaled structures used in the field of biotechnology and medicine for 
administration of bioactives range in particle size between 10 and 500 nm and rarely exceed 
700 nm.20 The nanosize of these particles allows various communications with biomolecules 
on the cell surfaces and within the cells, in a way that can be decoded and designated 
depending on the biochemical and physiochemical properties of these cells.194 Therefore, 
the nano-devices in drug delivery system and noninvasive imaging offered various 
advantages over conventional pharmaceutical agents.194,195 To be used at their full capacity 
the designed nano systems have to be stable, biocompatible, and selectively directed to 
specific sites in the body after systemic administration. 
Nano-scale structures for drug delivery applications in different shapes could be prepared 
from different materials and biomolecules such as metals,196 proteins,197 lipids,198 
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biopolymers27 etc. Depending on the selected method of NPs preparation, the obtained 
nano-structures could be NCs or NSs. The NCs are vesicle structures in which the drug is 
confined to a cavity surrounded by a nontoxic polymeric membrane or coating, while the 
NSs are systems in which the drug is uniformly dispersed. The active therapeutic could be 
attached to the NPs shell, entrapped or dissolved, depending on the NPs target application. 
In addition, the shell of the NPs could be made from molecules which possess specific 
activity and can act directly from the NPs surface. When designing such nano-devices the 
controlled release of pharmacological actives to the targeted site of action at the 
therapeutically optimal rate and dose regimen has been a major goal.  
The nano-scale pharmaceuticals could be administrated alone or when incorporated into 
different carriers such as films, solid foam, nanofibrous matrix, or hydrogels. In the research 
area, a wide range of natural–origin polymers are being applied as carriers systems for 
active biomolecules or as cell carriers with application in the tissue engineering field. 
Polymers such as polysaccharides, due to their bio-characteristics, namely biocompatibility 
and similarity to the extracellular matrix (ECM) are classify as one of the most attractive 
options to be used in the tissue engineering field and drug delivery applications. Moreover, 
the polymeric scaffolds can be designed to release different bioactives and be can be easily 
engineered as possess different functional groups available for modification. 
 
2.4 Antibacterial nanocomposites to prevent bacterial contamination and 
transmission 
In order to prevent/reduce the transmission of microbial infections, it is necessary to develop 
materials with antioxidation, antibacterial and antifungal properties. Cost-effective and 
biocompatible materials have been used in the production of antibacterial nanocomposites 
that are able to prevent the transmission of bacteria and infections. Such nanocomposites 
find a wide application as hygienic products, for food packaging, water purification systems, 
filters, and medical equipment.  
 
2.4.1 Antibacterial nanoparticles-coated medical textiles 
The high potential of the nano-structured materials was illustrated by producing of functional 
textiles.  High performance antibacterial nanocomposites resulted from the surface 
modification of textiles with metallic and organometallic nanomaterials. However, the 
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development of stable hybrid NPs coatings on textiles, almost exclusively involves the use 
of precursors, chemical pre-treatment, or additional processing steps, such as thermal 
curing, which renders the production technology rather complicated, time-consuming, and 
cost-inefficient.199,200 For example, in a multi-step process, CS was covalently attached to 
previously oxidized cellulose, followed by the incorporation of ZnO microparticles into the 
CS layer by ‘equilibration-cum-hydrothermal’ approach.201 Another time-consuming process 
was employed to impart both antimicrobial and UV protection properties to cotton by padding 
with zinc oxide/chitosan NPs (ZnO/CS NPs) suspension followed by squeezing, high-energy 
drying and curing.202  
Considering the fact that fiber and film processing are the most difficult procedures of 
molding polymeric materials, bulk modification of continuous multi-filament yarns is an 
extremely sensitive process. The achieving of optimum process conditions is a main 
requirement. For example, Dastjerdi and colleagues have conducted (on a pilot plant scale) 
the bulk modification of filament yarns with various concentrations of nano-composite fillers 
via melt mixing of the two different silver-based nanocomposite fillers (silver/zinc and 
Ag/TiO2), and polymer powder in three different mixing methods - single and twin screw 
extruder as well as master batch preparation. Besides that the technique is considered as 
high-quality and environmental-friendly, it is limited to synthetic fibers and the particles 
situated in the central part of the filaments do not contribute to the antibacterial 
performance.203  
The sonochemistry has appeared as an efficient, simple, and fast technique for coating of 
different solid surfaces with NPs, overcoming the aforementioned manufacturing hurdles, 
namely the need of pre- or post-treatments and consequently long processing times.114,204 
Moreover, the application of high intensity US also prevents the NPs aggregation, whereas 
the obtained coatings are extremely stable and uniformly deposited on the substrates30 and 
it is nowadays widely employed for synthesizing and embedding of antibacterial NPs into 
textile materials in a single process. For example, Gedanken and coworkers have 
demonstrated the successful application of US as a method for the antimicrobial finishing of 
various textiles with metal and MeO NPs in a one-step process.100,101,204–206 The mechanism 
proposed for the deposition is based on the local melting of the substrate due to the high 
rate and temperature of the NPs thrown towards the solid surface by the sonochemical 
microjets (Figure 2.7).101 Antibacterial properties were imparted to the cotton bandages by 
the sonochemical synthesis and deposition of CuO NPs onto their surface. For the 
generation of CuO NPs, copper(II)acetate monohydrate was used as precursor. The 
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antibacterial efficacy of the nanocomposites was demonstrated against E. coli and S. aureus 
bacteria strains. Regarding the mechanism responsible for the antibacterial action of the 
NPs it is worthy to mention that the Cu2+ ions did not have antibacterial properties (in 
comparison with Zn2+ released from ZnO NPs). The authors attributed the antibacterial 
activity of nano-CuO to the generation of active species responsible for damaging the 
bacteria's cells.204 The same research group has also demonstrated that the antibacterial 
performance of sonochemically CuONPs coated cotton textiles withstand 65 washing cycles 
at temperature regimes used in hospitals.207 This research was in line with the industrial 
need to fabricate antibacterial textiles for hospital uses. Such materials answer the problem 
of the hospital-acquired infections as they are able to prevent/reduce the bacteria spreading 
in the hospital healthcare units.208 
 
 
Figure 2.7 Scheme of the sonochemical deposition of MeO NPs on a solid substrate209 
 
Our group has reported on a two-step process comprising cellulase pre-treatment followed 
by sonochemical synthesis and deposition of ZnO NPs on cotton fabric.141 The enzymatic 
activation was combined with sonochemical synthesis/deposition of NPs in order to increase 
the number of anchoring points (reducing sugar ends) available to the NPs on the cotton 
surface. The positive effect of the enzyme pre-treatment on the stability of the ZnO coatings 
was demonstrated after repeated washing cycles at hospital laundry regime (92°C). 
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Moreover, the fabrics coated with NPs after preliminary treatment with enzyme showed 
uniform NPs dispersion along the fibres, and particle sizes in lower nanometric range in 
comparison with non-treated fabric. Perelshtein et al. have applied one-step sonochemical 
process to obtain  antimicrobial coatings of titanium dioxide NPs (TiO2 NPs) on cotton. The 
produced nano coatings displayed antimicrobial effect (when light illuminated) against 
common antimicrobial pathogens.100 In another study, ZnO NPs were synthesized and 
simultaneous deposited on the surface of cotton bandages using US irradiation. The formed 
ZnO NPs were homogeneously dispersed on the cotton surface. In line with the concerns 
for the NPs toxicity, the authors performed leaching test for evaluating the stability of the 
coatings. It was found that the concentration of zinc ions in the leaching solution increases 
by increasing the temperature, however, no NPs presence in the solution was detected by 
transmission electron microscope (TEM) and dynamic light scattering (DLS) analysis. These 
findings indicated that during the sonochemical process the NPs were strongly anchored to 
the textile substrate. 
The coating of fabrics with polymer NPs by US was also demonstrated. Tannic acid NPs 
were synthesized from an aqueous solution without the use of stabilizers and embedded on 
to cotton textiles in a one-step sonochemical process.103 The obtained materials possessed 
antimicrobial and anti-inflammatory properties. The anti-inflammatory properties were 
assessed in terms of inhibition of inflammatory enzymes (myeloperoxidase (MPO) and 
collagenase) activities. It was found that the inhibitory effect of the tested specimens was 
directly proportional to the concentration of organic compound used for bandage coating. 
The authors assumed that tannic acid NPs exhibited their functions from the surface of the 
cotton bandages. 
In recent years, Morsali and coworkers have demonstrated in several studies the NPs 
coating of polyester and silk fibers through sequential dipping steps in alternating bath of 
metal salts under US.156,210,211 For example, silver bromide NPs were coated onto polyester 
fabrics by sequential dipping steps in alternating bath of potassium bromide and AgNO3 
under US irradiation.156 It was demonstrated that the NPs size and morphology depend on 
the US power, sequential dipping steps and precursor concentration. The results suggested 
that an increasing of the sequential dipping steps and salts concentration lead to an 
increasing of the particles size, while an increase in the sonication power is accompanying 
with decreasing the size of the particles. 
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2.4.2 Potential of sonochemical processing in manufacturing of 
functional materials  
The use of US in laboratory reactions is becoming commonplace, and the extension of the 
technology to industrial-scale reactions is likely to follow. Underlying these developing 
technologies are the recent advances in our understanding of the nature of cavitation and 
the chemical effects of US. The sonochemical coating route could be easily scaled-up to 
meet the requirements of large-scale textile coatings. Recently, the European project SONO 
(FP7-228730, http://www.fp7-sono.eu/), where our group was a key partner, demonstrated 
the development of a pilot line for the production of medical antibacterial textiles based on 
sonochemistry. The antibacterial efficiency of the produced medical textiles have been 
reported in several research papers30,204,208  and in validated in a clinical study.209  
Pilot scale installation for sonochemically assisted coating of textile fabrics with various kinds 
of NPs was designed by Abramov et al. (Figure 2.8).30 The principle of the developed 
machine (operating in a roll-to-roll mode) involved feeding the fabric through a gap between 
two flat vibrating plates driven by magnetostrictive transducers. The speed of the moving 
fabric could be regulated between 0.004 and 0.050 m/s. Up to 50 m of fabric can be 
continuously coat with CuO and ZnO NPs using this pilot machine. The obtained textiles 
were characterized in terms of coating morphology, structure and stability to washing. The 
antibacterial assay of the coatings demonstrated that the loading of the nano-oxide appear 
to be decisive for their biocide performance. The obtained cotton fabrics displayed good 
antibacterial activity towards E. coli, K. pneumoniae, S. aureus and MRSA.212 
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Figure 2.8 Photo of the roll-to-roll sonochemical pilot installation. In the inset the CuO-coated and 
uncoated spools are shown. The front panel is open to show the change in the color of bandage after 
coating with CuO NPs. In the inset, one can observe that with the deposition of CuO NPs the color of 
the bandage changed from white to brown. When the ZnO is deposited on the bandage, the white 
color is retained.30 
 
2.4.3  Antimicrobial nanocomposites for water disinfection 
Constructed wetlands in various designs are the most versatile systems for removal of 
pesticides, heavy metals, polycyclic aromatic compounds and pharmaceutical residues.214–
217 Currently, a major issue with these systems is related to the additional microbial 
contamination, especially the growth of undesired pathogen bacteria. 
Microbiologically unsafe water is a global problem and among major causes of preventable 
morbidity and mortality. The WHO reports that by 2025 half of the world’s population will be 
living in water-stressed areas with access only to inadequate drinking water.218 One such 
example is microbiologically contaminated water associated with transmission of so-called 
bacteria waterborne diseases such as diarrhea, cholera, dysentery and typhoid fever.219 
Annually 2.2 million diarrheal disease deaths are being linked with the consumption of 
contaminated water.220 The concerns about these diseases have even worsened during the 
last years due to the effects of global warming, namely extreme rainfall and flooding that 
contribute to the inordinate microbial proliferation in surface and groundwater.221,222 
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Strategies to efficiently recover wastewater acceptable for domestic or recreational 
purposes are therefore considered of global importance. 
Some conventional methods for treating microbiologically unsafe water, e.g. boiling, reduce 
most waterborne pathogens and it is nowadays widely used to disinfect household water.223 
However, these methods are only efficient for small volumes. Whenever the purification of 
larger volumes is required, the disinfection process involves the use of chemicals, such as 
chlorine, chloramines, iodine or ozone.224,225 Among them, the most accepted is the 
chlorination due to its efficiency and low price. Nevertheless, chlorine disinfection leads also 
to the formation of by-products as trihalomethanes,223,226,227 which are related with 
developing certain cancers or adverse reproductive outcomes.228,229 Many researchers are 
therefore investigating new sustainable techniques to disinfect large volumes of water 
without endangering the environment and the human health.230,231  
Recently, considerable interest has arisen in the application of nanotechnology for water 
purification. In particular, functional antibacterial NPs and their potential for disinfection or 
microbial control in system level water treatment. Nanomaterials are providing novel 
opportunities to develop more efficient and cost effective nano-structured and reactive 
membranes for water purification. Several nanomaterials, such as silver, CS, and TiO2, have 
found applications as antimicrobial agents in diverse products and industrial processes, 
including for water treatment.224 Among all, nano-silver have been widely used for water 
filtration applications to inactivate bacteria232 and viruses.233,234 Moreover, AgNPs have been 
demonstrated to possess remarkable antimicrobial properties  when employed in very low 
concentrations without harmful side effects.235–238 Another NPs that have great potential as 
water purification catalysts and redox active media are the TiO2 NPs. TiO2 NPs can be 
employed as both oxidative and reductive catalysts to degrade organic and inorganic 
pollutants; to reduce toxic metal ions under UV and as antibacterial agents for water 
purification.239240  
However, for disinfection purposes the NPs immobilization on preferably low-cost materials 
is necessary, where the permanent NPs binding ensures the disinfection efficiency during 
long-term exploitation.241 For example, cellulose acetate hollow fiber membrane loaded with 
AgNPs for water treatment were prepared via dry-jet wet-spinning technique. The fibers 
were active against E. coli and S. aureus after being immersed in water bath for 180 days, 
despite that 60 % of the initially loaded silver remained. However, during filtration the silver 
content in the hollow fiber was depleted quickly within 5 days and the material lost it 
antibacterial activity against both tested bacteria strains, meaning that silver content must 
 34 
 
be periodically replenished after permeation.232 In another approach, a two-step process 
was used to design composite membranes on a glass support consisting of 50 nm thick 
chitosan layer on a poly(acrylic acid)/poly(ethylene glycol) diacrylate layer. The obtained 
material possess antibacterial activity towards S. aureus and E. coli bacteria, and the 
antibacterial activity of the membrane improved with increasing chitosan content.242 In a 
similar way, nano-composite membranes incorporating other functional (e.g. catalytic, 
photocatalytic and antimicrobial) NPs into water treatment membranes can be developed. 
The strategies for the NPs immobilization of onto various 2D or 3D macroscopic surface 
mainly involve the NPs modification with polymers or molecules containing functional groups 
allowing their further anchoring on a target surface. However, for achieving this goal the use 
of facile and environmentally friendly method is an important issue. The potential application 
of bio-catalysts (enzymes) could results into direct immobilization of various functionalized 
NPs onto different substrates under mild conditions.  
 
2.4.4  Antimicrobial hydrogels for wound treatment 
Wide range of new functional dressing materials are frequently introduced to target different 
aspects of the wound healing process as a result of the existing variety of wound types 
(acute or chronic). The ideal wound dressings are defined as those capable to achieve rapid 
healing at reasonable cost coupled with minimal inconvenience to the patients. The wound 
treatment should be based on the controlled-release delivery of active substances directly 
into wound sites which promotes the wound healing process such as grow factors,243,244 
antimicrobials245 or inhibitors of deleterious enzymes found in wounds.246 Many of the new 
topical dressings are based on novel polymers and are employed for drugs’ disposal due to 
their physical characteristics (e.g. fluid affinity, water uptake, rheological properties) but 
mainly because of their suitability for delivery of therapeutic agents when maintaining the 
wound surfaces moist. 
Hydrogels are three-dimensional structures with high water content often comprising 
covalently cross-linked hydrophilic polymers. The extent of cross-linking allows for tuning of 
physical, chemical and biological properties, which in the case of biopolymers are usually 
coupled with the intrinsic biocompatibility and similarity with the ECM of various tissues. 
Hence, biopolymer hydrogels are used for a wide range of biomedical applications such as 
drug carriers or composite matrices for tissue engineering.247,248 For instance, they appear 
attractive alternatives to conventional wound dressings to overcome their common 
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disadvantages such as low flexibility, lack of porosity and high adherence to wound surface 
that provokes painful removal.249 Additionally, the hydrogel-based wound materials provide 
and maintain beneficial for wound healing moisture environment.  
Compounds with intrinsic antimicrobial properties, e.g. polyphenolic molecules or metal 
oxides, could be added to polymer mixtures prior to gelation, targeting their sustained or 
controlled release from the hydrogel platform.250,251 In one such approach, plant polyphenols 
were encapsulated for protection and delivered from the biopolymeric NPs or matrices to 
improve the resistance of cells to oxidative stress, and to inhibit bacteria growth and 
deleterious chronic wound enzyme activities.246,252 Their processing into nanoscale particles 
is yet another attempt to improve their bioavailability and increase the efficiency in order to 
reduce the administration doses.253 Further integration of the NPs within a hydrogel platform 
aiming their protection and controlled/sustained release is expected to aid in the 
development of more efficient drug delivery systems for e.g. medical applications.251 
Polysaccharides, such as cellulose and starch, are the most abundant natural polymers in 
the biosphere. Naturally occurring alginate and chitosan are well known wound management 
materials due to their biological and haemostatic properties, which also facilitate the wound 
healing process.254 These are often applied in combination with pharmaceutical agents as 
bioactive dressings capable for sustained, and thus prolonged delivery of actives to the 
wound site.255 CS and its derivatives are potentially exploitable in the surface modification 
of colloidal carriers to modulate the bio-distribution of drugs and/or control their 
absorption.256–258 CS materials have been widely used as a topical dressing to treat wound 
and burn infections not only because of its intrinsic antimicrobial properties, but also by virtue 
of its ability to deliver extrinsic antimicrobial agents to wounds and burns. Another, promising 
approach for designing of hydrogel wound dressings are based on collagen or 
glycosaminoglycans (GAG) such as hyaluronan and chondroitin sulfate, which are found in 
the ECM.259,260 The GAG molecules can be chemically modified, creating new bio-materials 
with important bio-medical applications e.g. delivery of growth factors to the wound or as 
scaffolding material for tissue regeneration.261,262 Dressings prepared from chemically-
crosslinked GAG hydrogel films acts as bio-interactive wound dressings participating 
actively in the wound healing process rather than simply being passive barriers to 
desiccation.  
To achieve the polymer gelation different physical and chemical cross-linking strategies 
have been employed. The physical cross-linking can be achieved by changing the physical 
entanglements or by non-covalent physical associations, such as secondary forces 
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(hydrogen, ionic, or hydrophobic bonding).263,264 For example, the physical characteristics of 
the hydrogels could be modulated to the desired ones by changing pH, ionic strength and 
temperature of gelation.265,266 It was demonstrated that the mechanical properties of collagen 
gels are easily tuned by varying those parameters.267 In another study, it was shown that the 
ionotropic gelation method for formation of crosslinked CS can be modified from ionic cross-
linking to deprotonation by adjusting the pH of tripolyphosphate. In such conditions the CS 
ionic cross-linking takes place at lower pH, while the deprotonation mechanism occur when 
higher pH is used.268 A powerful approach for the generation of new materials with desired 
properties are the supramolecular interactions. Such hydrogel materials based on 
supramolecular self-assembly synthesis attracted special interest in the biological and 
electronics fields. The supramolecular self-assembly of cyclodextrins and polymers has led 
to the development of novel supramolecular hydrogels for drug delivery applications. For 
example, supramolecular hydrogel suitable for relatively long-term sustained controlled 
release were formulated based on the complexation α-cyclodextrin with various triblock 
copolymers bearing a hydrophobic block.263,269 The general advantage of physically cross-
linked hydrogels lies on a forming a gel without the need for chemical modification or the 
addition of cross-linking entities which make them suitable for in vivo practices. However, 
such networks held together by physical interactions only form mechanically weak scaffolds, 
resulting in fast erosion or degradation which limits their applications.270 Because of these it 
is difficult to decouple hydrogels variables such as gelation time, network pore size, chemical 
functionalization, and degradation time, restricting the design flexibility.271 The presence of 
non-homogeneities, free chain ends or chain loops and defects due to the formation of 
clusters of molecular entanglements, or hydrophobically- or ionically-associated domains 
can be also observed.  A low viscosity liquid phase or syneresis of the hydrogel after the gel 
formation is another drawback of solely physical networks.272 For these reasons, chemically 
cross-linkable systems allowing the formation of covalent bonds in situ have been 
developed. The chemical cross-linking process requires the addition of small molecules or 
conjugated directly to reactive pre-polymers. Chemical cross-linking of biopolymers to 
produce hydrogels results in higher mechanical properties compared to the physically 
assembled materials. However, the residual toxic chemicals and organic solvents employed 
often make them unsuitable for biomedical applications due to the toxic effects on human 
cells.273,274 The formation of free radicals or the nonselective reactivity with nucleophiles 
found in biomolecules such as proteins can cause undesired side reactions such as 
inflammation.275,276 As an alternative, covalently cross-linked gels could be obtain in situ via 
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enzyme-catalyzed reactions applying mild conditions and avoiding the use of harsh 
chemicals.277,278 Such enzyme cross-linking systems are exploitable for encapsulation of 
various bio-entities (e.g. active agents and/or cells) and for further application in the 
pharmaceutical industry.279 For example, peroxidase-catalyzed oxidation of CS derivatives 
was used for the preparation of biocompatible hydrogels for cartilage tissue engineering and 
drug delivery.280,281 The sustained release of therapeutic proteins produced by genetically 
engineered to secrete an anticancer drug (interleukin-2) cells through 4 % gelatin hydrogels 
enzymatically cross-linked by microbial transglutaminase was recently reported. The 
findings in this study have demonstrated that the enzymatically cross-linked hydrogels were 
not only biocompatible, but also have suitable transport properties that would facilitate the 
design of sustained drug release devices.282  
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3 Objectives of the thesis 
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The main objective of this thesis is the development of antibacterial nanocomposite coatings 
and materials aimed at reduction/prevention the transmission of infections and bacteria. The 
increasing bacterial resistance to the most powerful antibiotics and the frequent occurrence 
of nosocomial infections are of great concern since microbial contamination is a serious 
issue involving multiple human environments, including the health care and biomedical 
industries, water purification systems, and food packaging and storage. The nanoparticles 
based materials and coatings represent one of the most promising strategies for overcoming 
microbial resistance.  To this end, the following specific objectives have been set up:  
 
 The development of antibacterial medical textiles by a sonochemical process. 
The use of antibacterial textiles is in the list of preventive measures to reduce the 
bioburden in clinical settings and consequently diminish the risk of healthcare 
associated infections.  
 Development of stable hybrid nanocoatings on medical textiles using 
a one step sonochemical approach. The combination of biopolymers and 
metal oxide nanoparticles to develop hybrid nanocoatings is expected to 
provide enhanced antibacterial efficiency and improved biocompatibility due 
to the synergistic effect of both compounds. The exploitation of ultrasound 
coating technology will assure the nanocoating uniformity and stability. 
 Improving the uniformity and adhesion of the antibacterial 
nanoparticles onto textiles by a simultaneous sono-enzymatic coating 
process. The ultrasound will be employed to boost the rate of the enzymatic 
hydrolysis and create on the cotton surface a larger number of reducing 
sugar ends for better nanoparticles adhesion and durability of the 
antibacterial effect. 
 
 Development of hybrid biopolymer-metal based nanoparticles and 
nanocomposites for water disinfection. Amino-functional biopolymers will be 
used as doping agents to stabilize concentrated colloidal dispersions of silver 
nanoparticles, additionally providing the particles with functionalities for covalent 
immobilization. Further, antimicrobial material with potential for water remediation 
will be designed via enzyme-assisted assembling of the hybrid biopolymer-silver 
nanoparticles and phenol bearing filter matrices. 
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 Formation of nanocomposite hydrogels for localized delivery of nano-
therapeutics to wounds. Biopolymer (thiolated chitosan) hydrogels will be loaded 
with sonochemically processed nanoscale phenolics serving as active compound in 
an enzyme-assisted gelation process. The developed nanocomposite is aimed at 
modulating the enzymes activity and microbial load in chronic wounds.  
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4 Materials and Methods 
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4.1 Reagents  
Bleached woven 100 % cotton fabric (144 g/m2, warp/weft density 25/21 threads/cm) was 
provided by Davo, Romania. Low molecular weight chitosan (15 kDa, 87 % DDA) supplied 
by Kitozyme (Belgium) was used in the preparation of ZnO/CS and Ag/CS hybrid NPs and 
was dissolved prior to use in 1 % acetic acid. Water dispersion of ZnO NPs (size <100 nm), 
potassium sodium tartrate tetrahydrate, sodium hydroxide, 1,1-diphenyl-2-picrylhydrazyl 
radical (DPPH•) and 3,5-dinitrosalicylic acid (DNSA) were purchased from Sigma-Aldrich 
(Spain).  
Granulated cork with mean particle size of ~0.5 cm was provided by the Catalan Cork 
Institute. Silver nitrate (AgNO3), sodium borohidride (NaBH4), hydrochloric acid, sodium 
hydroxide and ethanol were of analytical grade, purchased from Sigma-Aldrich (Spain). 
Microcrystalline cellulose (Fluka, Avicel PH-101) dried at 105 °C for 2 h was used for the 6-
deoxy-6-(ω-aminoethyl) aminocellulose (AC, ~15kDa) preparation. First, tosyl cellulose was 
prepared using the synthesis method of Rahn et al.,283 obtaining the product with a degree 
of substitution (DS) of 0.8. Ethylendiamine was then added in excess and the mixture was 
stirred for 3 h at 100 ºC. After precipitation in H2O the conjugate was filtered, washed several 
times with isopropanol and H2O, and finally dried in vacuum. 
For the preparation of chitosan hydrogels, chitosan with average Mw of 20 kDa and 
acetylation degree of 18.54 % was provided by KitoZyme (Belgium). Ellman's reagent (5,5’-
dithiobis(2-nitro-benzoic acid)), 2-iminothiolane hydrochloride (Traut's reagent, TBA) and 
epigallocatechin gallate (EGCG) were purchased from Sigma-Aldrich (Spain).  
 
4.2 Enzymes 
Cellulase formulation Kappacell ETU 39 for biopolishing of cotton textiles (5.86 mg/mL 
protein, 1.2 mM glucose equivalents released per min, averaged over 60 min, pH optimum 
5 - 8) was purchased by Kapp-Chemie GmbH & Co. KG (Germany). Horseradish peroxidase 
(HRP, 1 U will oxidize 1 µmole of 2,2’-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) per 
minute at pH 5.0 and 25 °C) isolated from horseradish roots (Amoracia rusticana) was 
purchased from Sigma-Aldrich. 
Laccase (EC 1.10.3.2 Trametes sp. laccase, Laccase L603P) was provided by Biocatalysts, 
UK. Laccase activity was determined by oxidation of 5 mM 2,2'- azino-bis(3-
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ethylbenzthiazoline-6-sulfonic acid) (ABTS) substrate in 0.1 M succinic acid/succinate buffer 
(pH 5.0), followed by an absorbance increase at 420 nm and 50 ºC, to obtain 0.14 U/mg 
protein, where one unit is defined as the amount of enzyme necessary to oxidize 1 µmol of 
ABTS  per min (ε420 = 36,000 M-1 cm-1). Protein content was determined using the Bradford 
method, obtaining 0.125 mg protein per mg solid. 
MPO from human leukocytes (1550 U/mg solid: 1 U will produce an increase in absorbance 
at 470 nm of 1.0 per minute at pH 7.0 and 25 °C, calculated from the initial rate of reaction 
using guaiacol as a substrate) was from Planta Natural Products (Austria). EnzChek® kit 
was purchased from Life Technologies (Spain). 
 
4.3 Bacteria 
Gram-positive S. aureus (ATCC 25923) and Gram-negative E. coli (ATCC 25922) were used 
in the antimicrobial activity assays. Plate count agar, Baird-Parker agar, egg yolk emulsion 
and all other reagents for cell culture studies were purchased from Sigma-Aldrich unless 
otherwise specified. 
 
 
4.4 Experimental methods  
 
4.4.1 Simultaneous sonochemical coating of textiles with antibacterial 
ZnO/chitosan nanoparticles  
 
4.4.1.1  Ultrasound-assisted coating of cotton  
The sonochemical coating process was carried out using an ultrasonic transducer (Ti-horn, 
20 kHz, 750 W, Sonics and Materials VC750, USA). The power (21.5 W) and intensity (0.43 
W/cm3) were determined calorimetrically by measuring the time-dependent temperature 
increase in the ultrasonic vessel. The coating of the cotton samples (0.70 ± 0.05 g, approx. 
5 x 10 cm) was performed during 30 min at 20 ± 2 °C and 35 % amplitude, in a glass jacked 
vessel containing 50 mL ZnO NPs aqueous solution (0.2, 2 or 20 mM) and 0.3 % (w/v) 
chitosan. After sonication, the samples were thoroughly washed with distilled water to 
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remove the loosely fixed particles and chitosan. Control samples were prepared by 
deposition of ZnO NPs alone. 
 
4.4.1.2 Quantification of deposited ZnO 
The amount of ZnO embedded on the fabrics was determined after extraction with 0.5 M 
nitric acid. The concentration of solubilized Zn2+ ions was probed by inductive coupled 
plasma atomic emission spectroscopy (ICP – AES) analysis using ULTIMA JY2501 
(France). The obtained results are reported as mean values ± standard deviation (n = 3). 
 
4.4.1.3 Characterization of the coatings and nanoparticles 
The surface morphology of the coatings and size of the deposited NPs were studied with 
high resolution scanning electron microscope (HRSEM) model Quanta 200 FEG from FEI 
(USA). Additionally, the presence of zinc and chitosan on the coated fabric was detected by 
energy dispersive X – ray spectroscopy (EDS). ZnO/CS mass and molar ratios were 
determined by X-ray photoelectron spectroscopy (XPS) on a SPECS system equipped with 
an Al anode XR50 source operating at 150 mW and a Phoibos 150 MCD-9 detector 
(Germany). The morphology of the ZnO NPs in the remaining after the sonochemical 
process suspensions was investigated by a Ziess Neon FIb microscope (Carl Zeiss, 
Germany) in scanning transmission electron microscopy (STEM) mode operating at 30 kV 
acceleration voltage. The samples for observation were drop-casted on a TEM holey carbon 
grid. Additionally, STEM images were taken to evaluate the leaching of the NPs from the 
fabrics. Prior to STEM analysis the coated fabrics were incubated for 1 h in 0.3 mM KH2PO4 
solution at 37 °C and 230 rpm. 
 
4.4.1.4 Antibacterial tests 
Antimicrobial activity of the coated samples was assessed according to the standard shake 
flask method, recommended by the American Society for Testing and Materials (ASTM) for 
permanently immobilized active agents on fabrics (ASTM-E2149-01). The method provides 
quantitative data for measuring the reduction rate in number of colonies formed, converted 
to the average colony forming units per milliliter of buffer solution in the flask (CFU/mL). For 
preparation of E. coli and S. aureus suspensions, a single colony from the corresponding 
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stock bacterial cultures was used. The culture was then inoculated overnight in 20 mL sterile 
nutrient broth (NB, Sharlab, Spain) in a 100 mL Erlenmeyer flask and incubated at 37 ºC 
and 110 rpm. The inoculated bacterial culture was diluted with sterile buffer (0.3 mM 
KH2PO4) until solution absorbance of 0.28 ± 0.01 at 475 nm was reached, which 
corresponds to 1.5 ÷ 3.0 x 108 CFU/mL. This bacterial culture was then diluted appropriately 
into sterile buffer solution to obtain a final concentration of 1.5 ÷ 3.0 x 105 CFU/mL (working 
bacterial dilution). Thereafter, the cotton fabrics (0.035 g) were incubated with 5 mL of 
bacterial suspension at 37 ºC and 230 rpm. For determination of the inoculum cell density 
the suspensions were withdrawn before introducing the textile sample and after 15, 30 and 
60 min in contact with the fabrics. These suspensions were serially diluted in sterile buffer 
solution, plated on a plate count agar and further incubated at 37 ºC for 24 h to determine 
the number of surviving bacteria. Antimicrobial activity is reported in terms of percentage of 
bacteria reduction calculated as the ratio between the number of surviving bacteria before 
and after the contact with the coated textiles using the following formula: 
Bacteria reduction (%) = ((A-B) / A) x 100 (Equation 4.1) 
where A and B are the average number of bacteria before and after the contact with the 
coated textiles, respectively. 
The durability of the antibacterial effect was evaluated after performing 10 washing cycles 
in a laboratory dyeing machine (Ahiba Nuance, Datacolor ) at 75 °C, 30 rpm, for 15 min with 
0.1 g/L non-ionic surfactant Cotemol NI (Colorcenter, Spain), in liquor to good ratio 30:1.  
 
4.4.1.5 Cell culture 
The BJ-5ta cells (human foreskin fibroblasts, ATCC-CRL-4001) were maintained in 4 parts 
Dulbecco’s Modified Eagle’s Medium (DMEM, ATCC) containing 4 mM of L-glutamine 
(ATCC), 4500 mg/L glucose, 1500 mg/L sodium bicarbonate and 1 mM sodium pyruvate, 
and 1 part of Medium 199 supplemented with 10 % (v/v) of fetal bovine serum (FBS) and 10 
g/mL Hygromycin B, at 37 ºC in a humidified atmosphere with 5 % CO2. The culture medium 
was replaced every 2 days. At pre-confluence, cells were harvested using trypsin-EDTA 
(ATCC-30-2101, 0.25 % (w/v) trypsin / 0.53 mM EDTA solution in Hank’s BSS without 
calcium or magnesium) and seeded at a density of 4.5 x 104 cells/well in a 96-well tissue 
culture-treated polystyrene plate (Nunc, Spain). 
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4.4.1.6 Cytotoxicity evaluation by indirect contact 
Coated fabric samples (25 mg) were first sterilized under UV light for 1 h. The samples were 
then placed in contact with 3 mL of complete growth medium (DMEM) in a CO2 incubator at 
37 °C for 1 and 7 days. At the end of these periods, the samples were removed and the 
growth media withdrawn. Medium without the contact with the cotton was used as a negative 
control, whereas a 30 % dimethyl sulfoxide (DMSO) prepared in fresh culture medium was 
used as a toxicity positive control.  
The previously seeded cells were put into contact with the withdrawn culture media and 
incubated at 37 °C in a humidified atmosphere of 5 % CO2 for 24 h. The cells were further 
examined for signs of toxicity using Alamar Blue assay kit (AlamarBlue®, Invitrogen). 
Resazurin, the active blue ingredient of the kit, is a nontoxic, cell permeable compound that, 
once in a viable cell, is reduced to red colored resorufin. AlamarBlue® was diluted in culture 
medium and added to each well after aspirating the culture medium containing the samples. 
After 4 h incubation at 37 ºC the absorbance at 570 nm was measured, using 600 nm as a 
reference wavelength, in a microplate reader Infinite M200, Tecan (Austria). The quantity of 
resorufin formed is directly proportional to the number of viable cells. The error bars for each 
data are the standard deviation of three independent measurements. No cell viability was 
detected after the contact with the positive control regardless of the incubation time (data 
not reported). 
 
 
4.4.2 Simultaneous sonochemical enzymatic coating of textiles with antibacterial 
ZnO nanoparticles 
 
4.4.2.1 Cellulase activity measurements 
The cellulase activity was measured using the filter paper (FPU) assay.284 Reactions were 
carried out in 50 mL test tubes with Whatman No. 1 filter paper strip (1 x 6 cm, 50 mg) in 1.0 
mL distilled water and 0.5 mL enzyme formulation. The mixtures were incubated at 
temperatures ranging from 20 to 65 °C for 1 h. Thereafter, a colorimetric reagent (DNSA) 
was added to quantify the amount of reducing sugars. The DNSA solution was prepared by 
dissolving 120 g sodium potassium tartrate in 80 mL of previously heated (60 °C) 0.2 M 
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NaOH, prior to addition of 200 mL of 96 mM DNSA and volume completion to 400 mL with 
distilled water. The reaction mixtures were placed in a boiling water bath for 5 min, cooled 
to room temperature and diluted with 20 mL distilled water prior to measuring the 
absorbance at 540 nm with Infinite M200 (Tecan, Austria) multiplate reader. All experiments 
were performed in triplicate.  
 
4.4.2.2 Enzyme stability in US field 
One mL of cellulase product diluted to 50 mL with water was subjected to US irradiation (20 
kHz, 21.5 W, 17.30 W/cm2, 0.43 W/cm3 and 35 % of amplitude) for 30 min at temperatures 
ranging from 20 to 60 °C. After the treatment, enzyme aliquots (0.5 mL) were incubated for 
1 h at 55 °C with Whatman No. 1 filter paper strip (1 x 6 cm) and the reducing sugars 
released were measured using the FPU assay as previously described. The residual 
enzyme activity was calculated as a percentage of the activity of the enzyme not exposed 
to US. The possible effect of the sonochemical treatment on the tertiary and secondary 
structure of cellulase was assessed by measuring the intrinsic fluorescence of the enzyme 
as a result of protein unfolding and denaturing. For the purpose of the assay, cellulase water 
solutions not exposed (control) and exposed to US treatment (30 min) were evaluated. The 
fluorescence was measured at room temperature (25 ± 1 °C) with Quanta Master 4 
spectrofluorometer (PTI, USA) at 280 nm excitation wavelength (slit = 2 nm), 300 - 450 nm 
emission wavelength (slit = 2 nm) and 1200 nm/s of scanning speed. 
 
4.4.2.3 Effect of the US parameters on the enzyme performance 
To study the hydrolytic potential of the cellulase toward cellulose substrate under sonication, 
the US amplitude of vibration (and thus intensity) was varied to determine its effect on the 
yield of the enzyme catalyzed reaction expressed in reducing sugars concentration.  For this 
aim, 1 mL of cellulase solution (diluted to 50 mL with water) was subjected to ultrasonic 
irradiation at different US amplitudes (range of 20 – 40 %) for 30 min at 55 °C and in 
presence of 0.5 g of Whatman No. 1 filter paper as a substrate. Thereafter, the liberated 
reducing sugars were determined using the aforementioned method (section 2.4.2.1., FPU 
assay). Control treatments without enzyme were carried out in parallel. All results are 
reported as mean values ± standard deviation (n = 3). 
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4.4.2.4 Ultrasound-enzyme assisted coating of cotton with ZnO NPs 
The sonochemical coating was carried out using an ultrasonic transducer Ti-horn (20 kHz, 
Sonics and Materials VC750, USA). The US intensity (17.30 W/cm2), density (0.43 W/cm3) 
and power (21.5 W) used for the textile treatment were calorimetrically determined as 
described in 2.4.1.1. The cotton samples (5 x 10 cm, approx. 0.7 g) were immersed in the 
ultrasonic pot containing 50 mL ZnO NPs aqueous solution (1 mM) and 2 % of weight of 
fabric (owf) cellulase formulation and the coating of the cotton samples was carried out 
during 30 min at 55 ± 2 °C and amplitude of 35 %. To maintain the fabric at the bottom of 
the US pot without using any additional accessories, the fabric sample was cut bigger than 
the diameter of the pot (4 cm). Thereafter, the sample was folded in a way that its diameter 
is slightly wider than the diameter of the pot, thereby once placed at the bottom of the pot 
the contact/friction of its edges with the walls prevents it from moving during the 
sonochemical process. The sample area exposed to the US irradiation was used for the 
further experiments. The ultrasonic horn was dippen 1 cm in the ZnO dispersion at a 
distance from the fabric (at the bottom of the ultrasonic pot without any additional support) 
of approximately 3 cm. Thereafter the samples were thoroughly washed with distilled water 
to remove the loosely fixed particles. Controls were prepared by sonochemical deposition 
of ZnO NPs in presence of temperature-denatured enzyme.  
 
4.4.2.5 Characterization of the coatings 
The quantification of the amount of ZnO deposited on the fabrics (by ICP – AES) and the 
surface morphology studies of the coatings (by HRSEM) were carried out as described 
previously in section 4.4.1.2. For both washed and unwashed samples, the HRSEM images 
(section 4.4.1.2) were obtained from fabrics treated in three independent experiments. 
ImageJ software was used to build three size histograms of the ZnO NPs deposited on to 
the fabrics.  
 
4.4.2.6 Antibacterial test 
The antibacterial performance of the coatings were assessed as previously described in 
Section 4.4.1.4 
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4.4.3 Enzyme-assisted functionalization of cork surface with antibacterial 
biopolymer/silver hybrid nanoparticles 
 
4.4.3.1 Preparation of biopolymer-doped silver nanoparticles 
Biopolymers, CS and aminocellulose (AC) were dissolved to reach 0.8 % (w/v) in 1 % 
CH3COOH (CS) and distilled water (AC). The pH of the solutions were adjusted to 5 by 
adding 2 M NaOH in case of CS and 1 M HCl in case of AC. AgNPs synthesis was carried 
out by chemical reduction of Ag+ to elemental silver (Ag) using NaBH4 (17.5 mg/mL in dH2O), 
starting from aqueous solutions of AgNO3 (5 mg/mL) in presence of CS or AC. First, 2 mL 
of NaBH4 was added to 30 mL of a biopolymer solution under vigorous stirring, and then 
AgNO3 was slowly added to reach the final volume of 50 mL.  
 
4.4.3.2 Characterization of biopolymer-doped silver nanoparticles 
The hybrid structures were characterized using ζ potential for the particles charge, DLS for 
the mean particle size, UV-Vis spectrophotometry to check for the presence and intensity of 
the AgNPs surface plasmon resonance (SPR) band, and STEM to visualize the particles 
and evaluate their stability in the obtained dispersions. ζ potential was measured using 
Malvern ®Zetasizer Nano ZS, DLS measurements were performed using DL135 Particle 
Size Analyzer (Cordouan Technologies, France). Three samples of each AgNPs dispersion 
(in absence and presence of CS of AC) were processed acquiring 5 measurement cycles 
with 1 % signal-to-noise ratio. The data were analyzed using NanoQ 1.2.1.1 software. UV-
Visible spectra were recorded between 300-600 nm for the dispersions diluted 100 times in 
distilled water using a Cary 100 Bio spectrophotometer (Varian). The AgNPs in the 
dispersions were visualized by a Zeiss Neon FIB microscope (Carl Zeiss, Germany) in 
STEM mode operating at 30 kV acceleration voltage. The samples for observation were 
drop-casted on a TEM holey carbon grid.  
 
4.4.3.3 Immobilization of the hybrid biopolymer-doped AgNPs onto cork 
Prior to the treatment with biopolymer-doped AgNPs, the cork granules were cleaned with 
aqueous solution of HCl (pH 2), distilled H2O, NaOH solution (pH 10) and finally with 96 % 
EtOH, and dried at 60 ºC for 12 h. Thereafter, 1 g of the material was placed in a mixture 
containing 18 mL of AgNPs dispersion (pure, doped with CS or doped with AC – immediately 
after their preparation), 18 mL of 0.1 M succinic acid/succinate buffer (pH 5), and 0.5 mL of 
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laccase (final concentration 0.1 U/mL). The reaction was allowed to proceed for 24 h at 50 
°C and 30 rpm in a laboratory dying machine Ahiba (Datacolor). Control samples were also 
prepared using the same treatment conditions without laccase (in presence of hybrid 
biopolymer-AgNPs) and with laccase and CS or AC alone (without AgNPs). The treated cork 
was washed thoroughly with water to remove the loosely fixed particles and NaBH4 from the 
material, and finally dried at 50 ºC for 12 h.  
Fourier transform infrared spectroscopy (FTIR) was used to analyze the surface of the 
treated cork. IR spectra of the samples were collected in the range of 4000-600 cm-1 using 
Perkin-Elmer Spectrum 100 (USA) equipped with universal ATR sampling accessory, 
performing 64 scans for each spectrum. Scanning electron microscopy (SEM) was 
performed to examine the morphology of the AgNPs-biopolymer hybrids immobilized onto 
cork and to examine the presence of bacteria on the non-modified cork (control) and on the 
cork-AgNPs-CS composite. The micrographs with magnification ×30K were obtained using 
a Zeiss Neon FIB microscope (Carl Zeiss, Germany) operating in SEM mode.  
 
4.4.3.4 Antimicrobial activity of AgNPs embedded cork matrices 
The antimicrobial performance of treated cork matrices was assessed against E. coli and S. 
aureus using the dynamic shake ASTM E 2149-01 test, as described in section 2.4.1.4. The 
results were expressed as log10 of CFU/mL of buffer solution in the flask. Besides the 
unwashed matrices (only rinsed with water after the treatment), the antibacterial 
performance of the untreated and treated cork was evaluated after immersing those in water 
for 1, 2 and 5 days at room temperature while stirring (100 rpm) to mimic the environment 
in which the materials are intended to be used, i.e. water flow in constructed wetlands. 
Finally, the antimicrobial activity after 5 days washing is also expressed as a reduction 
percentage of the survived bacteria colonies. The results were expressed as log reduction in 
CFU counts.  
To study the viability of the bacteria accumulated on the cork surface, unmodified and 
functionalized with AgNPs-CS cork pieces were incubated with E. coli contaminated water 
for 16 h.  Thereafter, the cork samples were washed with sterile distilled water. To grow the 
alive bacteria, five of the washed cork granules were placed on Coliform agar and incubated 
at 37 °C for 24 h, while another five granules were used for SEM measurements in order to 
detect the presence of bacteria on the materials’ surface. Before the SEM analysis the 
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bacteria accumulated on the cork were subjected to fixation procedure preserving their initial 
structure.  Briefly, the samples were placed in 4% paraformaldehyde in phosphate-buffered 
saline (PBS) for 30 min, then washed twice with sterile PBS, and placed in 25, 50, 75 and 
96% ethanol for 10 min. The fixation was conducted at room temperature. 
 
4.4.4 Enzyme-assisted formation of nanospheres-embedded hybrid biopolymer 
hydrogels for wound healing 
 
4.4.4.1 Nanospheres preparation and characterization 
NSs were generated by applying 20 kHz ultrasonic irradiation (0.43 W/cm3 intensity and 35 
% amplitude) on the interface of water/oil mixture (15:6 (v/v)) containing 0.5 mM EGCG for 
3 min at 4 ºC. The NSs suspended in the aqueous phase were thereafter subjected to 
several cleaning steps after centrifugation (2000 rpm for 15 min) to remove the oil phase. 
Three samples of each NSs suspension were assayed by DLS at room temperature to 
determine the mean sphere size of the obtained phenolic NSs as described in section 
2.4.3.2. The NSs morphology was evaluated using a NIKON Eclipse Ti−S fluorescence 
microscope (Nikon Instruments, Inc., The Netherlands). The phenol groups of EGCG NSs 
and free solution were estimated according to the Folin-Ciocalteu method for determination 
of total phenol content 285 by monitoring the reaction at 760 nm in a microplate reader 
(Infinite M200, Tecan, Austria) and the results were expressed in gallic acid equivalents 
(GAE). Prior measuring the absorbance, the samples were filtered through Millex® GP 0.22 
µm PES filters (Merck Millipore Ltd., Spain) after which 200 µL of the filtrates were 
transferred to a 96-well microplate. 
 
4.4.4.2 Myeloperoxidase inhibition 
The MPO inhibition with the EGCG NSs and free solution was measured using guaiacol as 
a substrate. The samples were serially diluted in 50 mM phosphate buffer, pH 6.5 (in a 
concentration range of 0.0025 to 0.001 mM) and further 450 µL of each dilution was 
incubated for 1 h with 20 µL of 0.60 U MPO and 30 µL of guaiacol (167 mM) at 37 °C. The 
mixtures were then filtered through Millex® GP 0.22 µm PES filters (Merck Millipore Ltd., 
Spain) and 200 µL of the filtrates were transferred to a 96-well microplate. The reaction was 
 54 
 
started by adding 22 µL of 1 mM H2O2 and the absorbance increase was followed at 470 nm 
for 90 s. 
 
4.4.4.3 Collagenase inhibition 
The collagenase activity was measured using EnzChek® kit. Briefly, 80 µL of the EGCG 
free solution or NSs suspension, 100 µL of collagenase (0.5 U/mL) and 20 µL gelatin-
fluorescein conjugate (to a final substrate concentration of 100 µg/mL) were incubated at 
room temperature protected from light. After 6 h the fluorescence was measured (493/528 
nm) using a microplate reader Infinite M200, Tecan (Austria). For each sample, the 
background fluorescence values derived from the controls without the enzyme were 
subtracted. The measurements were performed in triplicate and the results are expressed 
as the percentage of collagenase inhibition compared to the control without EGCG. 
 
4.4.4.4 Antioxidant activity 
Radical scavenging activity of the EGCG NSs and free solution were determined by 
measuring the decrease in absorbance of 1,1-diphenyl-2-picrylhydrazyl radical (DPPH•) at 
517 nm. Different dilutions of the samples (100 µL) were incubated with 2.5 mL of DPPH• 
solution (9.84 mM) in methanol at room temperature in dark for 30 min. All experiments were 
carried out in triplicate. The antioxidant activity was calculated using the following formula: 
DPPH inhibition (%) = [1 – (A/Ao)] x 100  
where A0 is the absorbance of the negative control (DPPH solution alone) and A is the 
absorbance in presence of the EGCG solution/NSs suspension. 
 
4.4.4.5 Antibacterial tests 
S. aureus growth inhibition assay was performed in presence of the EGCG NSs or free 
solution. For the preparation of S. aureus suspension, a single colony from the 
corresponding stock bacterial culture was used. The culture was then inoculated overnight 
in 20 mL sterile NB (Sharlab, Spain) in a 100 mL Erlenmeyer flask and incubated at 37 °C 
and 110 rpm. In order to obtain the bacteria stock solutions the inoculated bacterial culture 
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was diluted with NB until reaching the absorbance of 0.01, monitored at 600 nm. Thereafter, 
250 µL undiluted (0.5 mM) and diluted (0.25; 0.1; 0.05; 0.025 mM) in NB EGCG NSs/solution 
were incubated with 250 µL of bacteria stock solution for 24 h at 37 °C and 230 rpm. After, 
the suspensions were serially diluted in NB, plated on a Baird-Parker agar, and further 
incubated at 37 °C for 24 h to determine the number of surviving bacteria colonies. 
Antimicrobial activity is reported in terms of percentage of bacteria reduction calculated as 
the ratio between the number of surviving colonies before and after the contact with the 
samples using Equation 4.1 (Section 4.4.1.4), where A and B are the average number of 
bacteria colonies at 24 h for bacteria incubated without (control sample) and with EGCG 
NSs/solution, respectively. 
 
4.4.4.6 Thiolation of chitosan 
The incorporation of thiol groups into chitosan was carried out following the procedure of 
Bernkop-Schnürch et al.286 First, chitosan was dissolved in CH3COOH (1% v/v) and TBA 
was added at the chitosan:TBA ratio 5:2 (w/w). The pH was then adjusted to 6 with 5 M 
NaOH. In order to avoid the oxidation of free thiols to -S-S- during the coupling reaction, 
dithiotreitol was added in a final concentration of 100 mM. The reaction mixture was stirred 
for 24 h at room temperature. The obtained thiolated chitosan (TC) conjugate was purified 
by 24 h lasting different dialysis steps: first three times against 5 mM HCl containing 1 % 
NaCl, then two times against 5 mM HCl. Thereafter, TC and the control (non-thiolated 
chitosan) were freeze-dried and stored at 4°C until further use. The free thiol content in the 
TC conjugate was determined spectrophotometrically using Ellman’s reagent287 and found 
to be 878±14 µmol/g of conjugate. 
 
 
4.4.4.7 Hydrogels preparation and characterization 
Hydrogels were obtained by enzymatic cross-linking between 46 to 660 sec at room 
temperature, using horseradish peroxidase (9.65 U/mL) and hydrogen peroxide as an 
oxidizing agent. For the hydrogels containing EGCG NSs, the spheres were dispersed in 2 
% TC solution in a spheres:TC 10/90 (v/v) ratio prior to cross-linking. The gelation time (the 
time which it takes for the formation of gel) was determined using a vial tilting method by 
regarding the gel state when the solution does not flow for 1min after inverting a vial.288 The 
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morphology of the obtained hydrogels was studied by scanning electron microscopy (SEM, 
JSM 5610 scanning electron microscope (JEOL Ltd, Japan)). 
 
4.4.4.8 Swelling ratio and in vitro degradation of chitosan hydrogels  
TC hydrogels were cut into pieces of 3 mg and thereafter immersed in 2 mL distilled water. 
The samples were taken out at predetermined time intervals and weighed after removing 
the water adhered on their surface by gently blotting with filter paper. The swelling degree 
(DS) was determined using the following formula: 
DS (%) = [(Ww – Wi)/Wi] x 100 
where, Wi and Ww are the initial weight and weight of the wet sample, respectively (n=6 for 
each time point). 
To study the hydrogel degradation in water, hydrogels were previously freeze-dried and 
thereafter equally weighted (3 mg) prior to immersion in 2 mL distilled water at 37 °C. The 
samples were removed after 1, 7, 14, and 21 days and again freeze-dried. The percent mass 
loss was calculated as follows: 
Degradation (%) = [(Wi – Wd)/Wi] x 100 
where, Wi and Wd are the initial dry weight and the dry weight of the sample, respectively 
(n=6 for each time point). 
 
4.4.4.9 In vitro NSs release 
To study the release of EGCG NSs from TC platform, hydrogel pieces (0.2 g) loaded with 
NSs were incubated in 1 mL distilled H2O. The release of phenol NSs into the incubation 
solution was followed spectrophotometrically at 280 nm (EGCG NSs wavelength of 
maximum absorbance) at determined time intervals. The results are presented as an 
average percentage (of three repetitions) of the phenols released from hydrogels.  
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4.4.4.10 Cell culture 
The BJ-5ta cells (human foreskin fibroblasts, ATCC-CRL-4001) were maintained as 
described in section 2.4.1.5. and were further used to assess the samples’ cytotoxic effect 
after direct contact with the cells as detailed below.  
 
 
4.4.4.11 Cytotoxicity evaluation by AlamarBlue Assay 
Cells were seeded at a density of 4.5×104 cells/well on a 96-well tissue-culture-treated 
polystyrene plate (Nunc) one day before the experiments. Thereafter, cells were exposed to 
solutions of EGCG NSs, TC and their mixture in the concentrations 10 times lower that those 
used for the hydrogel preparation at a final volume of 150 μL and incubated at 37 °C in a 
humidified atmosphere with 5% CO2. After 24 h contact, the NSs were removed and the 
cells were washed twice with PBS and stained for signs of toxicity using AlamarBlue assay. 
To do so, 100 μL of 10% (v/v) AlamarBlue reagent in DMEM was added to the cells and 
incubated for 4 h at 37 °C, after which the absorbance at 570 nm was measured, using 600 
nm as a reference wavelength, in a microplate reader. The quantity of resorufin formed is 
directly proportional to the number of viable cells. BJ5ta cells relative viability (%) was 
determined for each sample and compared with that of cells incubated only with cell culture 
medium. H2O2 (500 μM) was used as a positive control of cell death. Data are expressed as 
the mean of three measurements, with a standard deviation as a source of error. 
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5.1 Sonochemical coating of medical textiles with antibacterial 
ZnO/chitosan hybrid nanoparticles 
     
 
This section is based on the following publication: 
Petkova P, Francesko A, Fernandes MM, Mendoza E, Perelshtein I, Gedanken A, Tzanov T, 
Sonochemical coating of textiles with hybrid ZnO/chitosan antimicrobial nanoparticles. ACS Applied 
Materials & Interfaces, 2014, 6 (2), pp 1164–1172 
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5.1.1 Introduction 
The properties of hybrid polymer-metal nanocomposites are influenced by the components 
interactions which affect the composite shape, size distribution and stability. Chitosan (CS) 
strongly complexes, unlike other natural compounds, with metal ions due to its free amine 
groups.289,290 Two models are proposed for hybrid CS and metal ions structures: “pendant 
model” where ion is bound to only one amino group of CS,291 and “bridge model” where ion 
is bound to several nitrogen atoms and hydroxyl groups of one or bridging more CS 
chains.292 This ability of CS was explored in our previous study293 to sonochemically 
synthesize zinc oxide (ZnO)/CS NPs (ZnO/CS NPs) and simultaneously deposit them on 
cotton fabrics. Here, the study is extended to the optimization of the sonochemical process 
in terms of metal oxide (MeO) concentration and reaction time in order to obtain efficient 
and durable antimicrobial textiles that do not cause toxic effects to human cells. 
Such development is in the scope of a general strategy to decrease the occurrence of 
nosocomial infections in clinical settings through sustainable manufacturing of efficient 
antimicrobial hospital textiles. The sonochemical process is carried out in aqueous solutions, 
in line with the current focus on development of environmentally friendly manufacturing 
technologies. The durability of the antimicrobial effect is also evaluated after multiple high-
temperature washing cycles used in hospitals against two medically relevant bacterial 
species – S. aureus and E. coli.  
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5.1.2 Characterization of the coated fabrics 
ICP measurements were performed for determination of zinc on the cotton treated with 
different ZnO NPs concentrations in the presence and absence of CS. As expected, 
increased ZnO NPs concentration in the coating process led to higher amount of zinc 
deposited on the fabric (Figure 5.1A). On the contrary, considerably less amount of zinc was 
detected on the fabrics treated in presence of CS. Moreover, the EDS analysis of the hybrid 
coatings detected the presence of N and Zn on the fabric, thereby confirming the deposition 
of both CS and ZnO (Figure 5.1B).  
 
Figure 5.1 (A) Amount of zinc sonochemically deposited on cotton fabrics from solutions of ZnO NPs, 
in absence (light grey bars) and presence (dark grey bars) of 0.3 % (w/v) CS, and (B) EDS spectrum 
of cotton coated with 2 mM ZnO in presence of CS. 
XPS analysis was conducted to determine the molar and mass ratios of ZnO/CS on the 
cotton fiber surface. Due to the large experimental groups, XPS results presented herein 
are for the hybrid 2 mM ZnO NPs/CS coating. The energy spectrum of the photoelectrons, 
produced by the x-rays photoelectronic effect allows the determination of the sample 
composition (up to 10 nm sampling depth). The position of the peaks (binding energies of 
electron orbitals) in the spectrum and their relative areas are used to quantitatively identify 
the composition of the sample surface (Figure 5.2A). Figure 5.2B shows high - energy 
resolution carbon C 1s spectrum obtained for the hybrid coating. Three peaks are assigned 
to the different chemical bonds of carbon atoms, namely C-O (286.21 eV), C=O / O-C-O 
(287.29 eV) and C-H / C-C (284.80eV). The N 1s spectrum peaks (Figure 5.2C) with binding 
energies of 399.35 eV and 401.9 eV were assigned to the chitosan amino and protonated 
amino groups, respectively. Zn 2p 3/2 spectrum is presented with only one peak with binding 
energy at 1021.97 eV (Figure 5.2D).293 Atomic concentrations obtained from XPS analysis 
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for Zn (14.87 %) and N (85.13 %) were used for calculation the molar (14.19) and mass 
(0.08) ratios of ZnO/CS within the hybrid coating.  
 
  
  
Figure 5.2 N and Zn XPS spectra of cotton sonicated in the presence of 2mM ZnO NPs and CS. 
 
The HRSEM surface analysis of the sample coated only with ZnO showed a dense layer of 
NPs on the fibers (Figure 5.3A, B). Comparatively lower amount of NPs with bigger average 
size was found on the fabric treated with ZnO/CS system (Figure 5.3C, D), in good 
agreement with the ICP data. It is hard to distinguish between the individual and hybrid 
ZnO/CS particles, because chitosan itself is able to form nanospheres under sonochemical 
irradiation that are similar in shape to the ZnO NPs.293 Indeed, the pure CS coating (Figure 
5.3E, F) appeared quite similar morphologically to the hybrid coating. Nevertheless, the NPs 
within the hybrid coating were bigger in size than the pure ZnO or CS particles, indicating 
that these probably were comprised of both components. It was reported that the mean 
diameter of CS NPs increased when metal ions were loaded to the polymer.294 On the other 
hand, the effect of CS on the metal NPs is resumed in its action as a controller of the 
nucleation or stabilizer.295,296  
A B 
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Figure 5.3 HRSEM micrographs of cotton fabrics coated with ZnO (A, B), ZnO/CS (C, D), and CS (E, 
F). Composition of the starting solution: 2 mM ZnO NPs and 0.3 % (w/v) CS. The images on the left 
were taken with 10 000x, whereas the right-side images were taken with 200 000x magnification. 
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To explain the differences in the amounts of ZnO deposited on the fibers, the remaining after 
the sonochemical process solutions were evaluated for the presence of ZnO NPs using 
STEM. Given the lower amount of Zn detected on the fabrics treated in presence of chitosan, 
it was expected that higher amount of MeO particles would be found in the corresponding 
remaining solution compared to the one remained after coating in absence of chitosan. 
Surprisingly, the ZnO NPs density was also lower in the solution left after the hybrid coating 
(Figure 5.4A). The lower amount of NPs both on the fabric and in the remaining solution 
could be explained only if the effect of pH on the solubility of both ZnO and CS is considered. 
ZnO dissolution occurs over a wide pH range,297 whereas the oxide is stable at pH 7.2 due 
to a minimal interference of the dissolution products. On the other hand, due to inter-
molecular and intra-molecular hydrogen bonding, chitosan can be dissolved only in aqueous 
solutions of organic or mineral acids below pH 7. At these conditions the stability of ZnO 
rapidly decreases due to reaction with acidic substances. It is thus expected that the addition 
of CS dissolved in CH3COOH to ZnO aqueous suspension will decrease the pH of the 
system and affect the ZnO stability. After CS addition the pH of the ZnO NPs suspension 
indeed dropped from 8.2 to 6.9. Zn2+ complexation could also contribute to the lowering of 
the system pH. Similar behavior was already reported for various metal ion systems 
containing CS.298–300 The complex reaction could be described according to the Lewis acid-
base theory, where the acid (Zn2+) is an acceptor of a pair of electrons, provided by the base 
(CS).298 Thus, the physicochemical properties of the individual composite components most 
probably dictate the formation of Zn2+/CS complex within the hybrid coatings. On the other 
hand, no NPs leaching was detected from the coated fabrics, revealing high stability of both 
ZnO and the hybrid coatings (Figure 5.4B). 
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Figure 5.4 STEM images taken to evaluate: (A) the NPs presence in the remaining solutions after 
the sonochemical coating of cotton fabrics with 2 mM ZnO in absence (top image), and presence 
(bottom image) of 0.3 % (w/v) CS; and (B) the NPs leaching into a solution incubated with the fabrics 
coated with ZnO (top image), and ZnO/CS (bottom image). 
 
5.1.3 Antibacterial activity 
Both ZnO and CS are largely reported as efficient antibacterial agents. The most widely 
accepted mechanism of ZnO antibacterial action involves the oxide dissolution to Zn2+ 
further associated with oxidative stress in bacteria cells and generation of ROS.129,301 ROS 
cause inhibition of cell enzymes, lysosomal and mitochondrial damage, and consequently 
cell death.302 The antimicrobial effect of CS depends on its molecular weight and varies 
among different microorganisms.303,304 Among the proposed mechanisms of CS 
antimicrobial action are: i) binding to the cell DNA to inhibit the protein synthesis, and ii) 
interaction with negatively charged microbial membranes to alter the cell permeability.305,306 
Recently, hybrid complexes of CS and metal ions showed several-fold enhancement of their 
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antibacterial activity as compared to the individual components.182,298 In addition, the 
antibacterial activity was directly proportional to the amount of metal ions in these 
complexes. 
In a next step, the antibacterial efficiency of the sonochemically generated on cotton fabrics 
hybrid Zn2+/CS was evaluated against two medically relevant bacterial species and further 
compared to the effect of pure ZnO coatings. The Zn2+/CS coatings reduced the viabilities 
of both S. aureus and E. coli, though to a different extent (Figure 5.5). As expected, the 
presence of chitosan enhanced the antibacterial effect of the coatings against both strains 
regardless of zinc concentration in the complex. However, the fabrics coated with the lowest 
NPs concentration (0.2 mM) in presence of CS brought about only 30 % reduction of bacteria 
viabilities. Increasing the amount of zinc in the coatings resulted in enhanced antibacterial 
effect. The coatings with 2 and 20 mM ZnO showed comparable antibacterial efficiency for 
both bacteria. Thus, all further experiments were carried out with the fabrics treated with 2 
mM NPs, as this concentration was considered appropriate to produce efficient antimicrobial 
textiles. 
 
     
Figure 5.5 Antibacterial activity of ZnO (light grey bars) and Zn2+/CS (dark grey bars) coated cotton 
fabrics towards S. aureus and E. coli after 15 min of contact. 
 
In Table 5.1 the antibacterial activity of fabrics coated with 0.3 % (w/v) CS, 2 mM ZnO, and 
the corresponding hybrid is shown as a function of the incubation time. The hybrid coating 
led to 98 % reduction of bacteria growth for S. aureus after 60 min, whereas ZnO and CS 
alone reduced the bacteria growth by 61 and 31 %, respectively. It is worthy to mention that 
the CS coating reached its maximum activity against S. aureus already after 30 min, while 
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the longer incubation time resulted in improved antimicrobial effect for the coatings 
containing ZnO. In the case of E. coli a progressive improvement in antibacterial effect was 
observed for both CS and pure ZnO coatings. The different efficiency of the CS-containing 
coatings against E. coli (78 % after 60 min incubation) in comparison to S. aureus (31 %) 
could be due by the low Mw of the biopolymer (15 kDa) used in the study. Low Mw chitosans 
are reported to be more active against Gram-negative than against Gram-positive 
bacteria.304 On the other hand, the hybrid coating reduced the bacterial viability by more 
than 96 % even after 15 min of incubation. Nearly 100 % reduction was observed for both 
fabrics treated with ZnO and the hybrid coating after 60 min incubation. 
 
Table 5.1 Antibacterial activity of the coated fabrics against S. aureus and E. coli after different 
incubation time. 
Staphylococcus aureus 
Reduction in viability, % 
Coating     15 min     30 min     60 min 
CS 26.84 ± 4.07 33.00 ± 1.94 30.99 ± 1.81 
2 mM ZnO NPs 15.39 ± 1.93 41.50 ± 2.12 60.77 ± 0.16 
2 mM ZnO NPs/CS 63.15 ± 0.23 81.62 ± 3.58 98.48 ± 0.22 
 
Escherichia coli 
Reduction in viability, % 
Coating     15 min    30 min     60 min 
CS 25.18 ± 1.02 72.66 ± 1.02 78.06 ± 0.51 
2 mM ZnO NPs 79.88 ± 0.60 89.81 ± 1.31 99.86 ± 0.02 
2 mM ZnO NPs/CS 96.60 ± 0.12 96.72 ± 0.18 99.88  0.04 
 
 
5.1.4 Durability of antibacterial effect 
Despite the advances in antimicrobial finishing, the hospital textiles still become 
contaminated at use.307 Frequent laundering is therefore necessary in order to entirely 
prevent the transfer of pathogens. In order to evaluate the durability of the antimicrobial 
coatings, the fabrics were subjected to 10 washing cycles at 75 ºC and their antibacterial 
performance was assessed afterwards against the selected bacterial strains. The results 
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are expressed in percentage of remaining biocide activity compared to non-washed fabrics 
(Figure 5.6A). The ZnO coating retained about 50 % of its initial activity against both strains, 
whereas the hybrid coating preserved about 70 % and 85 % of the efficacy against S. aureus 
and E. coli, respectively (illustrated at Figure 5.6B). It is the presence of CS that improved 
the washing stability of the hybrid coating, as the individual CS coating was showed to 
maintain between 85 and 90 % of its initial activity. The sonochemical deposition of polymers 
onto solid surfaces usually results in their stable embedding on the substrate.308 Under 
ultrasound irradiation of liquids, the microjets and shock waves produced after cavitation 
collapse are able to drive the biopolymers at such high velocities towards a solid surface 
that fusion and strong adherence by physical or chemical interactions with the fabric occurs 
during collision.309 Conversely, sonochemically deposited metal oxides are not particularly 
stable and additional pre-treatment of the solid substrate are required for improved coating 
stability.141 
 
 
Figure 5.6 (A) Percentage of remaining antibacterial activity of the coatings after 10 washing cycles 
at 75 °C against S. aureus (light grey bars) and E. coli (dark grey bars), after 15 min of contact. (B) 
Images of antibacterial activities of the Zn2+/CS fabrics before and after washing. 
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5.1.5 Cell viability 
Although zinc and copper oxides are safer alternatives to more toxic silver, the studies 
continue to highlight their biological toxicity using soil and aquatic organisms310 and 
mammalian cell lines.311,312 The toxic action of metal and MeO NPs is mainly a consequence 
of the release of cytotoxic metal ions from such systems.301,313 Since ZnO NPs partially 
dissolve in water, their dissolution in aqueous systems is expected to involve both ionic and 
particulate species. Solubilized Zn2+ proved to contribute substantially to the cytotoxicity of 
ZnO NPs.165,310 Another assumption claims that ZnO produces toxic species associated with 
its photocatalytic property. ROS generated under environmentally relevant UV radiation 
increase significantly the toxicity of these systems to human cells.301 Some studies even 
report the generation of ROS in absence of photo-chemical energy.314,315 It is therefore 
crucial to evaluate the potential toxicity to humans of the systems comprising ZnO. 
After optimizing the ZnO concentration in the antimicrobials-coated textiles, the potential 
cytotoxicity of these systems was evaluated for medical application requiring contact with 
human skin. Indirect contact method was used to determine the potential toxicity that CS, 
ZnO or hybrid nano-coatings might induce to fibroblasts cell culture. During the first 24 h the 
cultured cells were metabolically active with no difference in cell viability observed among 
the experimental groups. However, after one week of contact with the ZnO coated fabric cell 
viability dropped to less than 5 %. In contrast, the CS and the hybrid coating did not induce 
considerable cell toxicity even after one week. As in the case of bacteria killing, ZnO NPs 
induce oxidative stress in human cells through the generation of free radicals and ROS.316 
The reason for the lower cytotoxicity value in the case of the hybrid coating could be the 
lower amount of ZnO impregnated on the fabric compared to the fabric treated with ZnO 
alone (Figure 5.1A). It could be also hypothesized that the CS inhibits the generation of ROS 
below the threshold of oxidative stress due to its antioxidant capacity.317 
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Figure 5.7 Human skin fibroblasts viability after 24 h (light grey bars) and 1 week (dark grey bars) 
contact with the coated cotton fabrics. 
 73 
 
5.1.6 Conclusions 
Hybrid antimicrobial coatings were generated on cotton fabrics via a one-step sonochemical 
deposition of ZnO NPs in presence of chitosan. The process was optimized in terms of ZnO 
concentration and ultrasound irradiation time towards obtaining highly efficient and non-
cytotoxic antibacterial textiles for use in hospitals. The synergy between ZnO NPs and 
chitosan resulted in enhanced antibacterial efficiency against S. aureus and E. coli even at 
low ZnO concentration, compared to the individual ZnO and chitosan coatings. The 
antimicrobial effect of the treated fabrics was resistant to multiple washing cycles at 75 ºC 
according to the laundry regimes used in hospitals. Moreover, the presence of chitosan 
substantially improved the biocompatibility of the ZnO coatings avoiding the risk of adverse 
effects on human health. The sonochemically generated antimicrobial textiles showed 
potential, in terms of easiness of the process coupled to enhanced antimicrobial effect and 
high washing stability, for uses in hospital environment to prevent the spread of nosocomial 
infection. 
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5.2 Simultaneous sono-enzymatic coating of medical textiles with 
antibacterial ZnO nanoparticles 
 
 
 
This section is based on the following publication: 
Petkova P, Francesko A, Perelshtein I, Gedanken A, Tzanov T, Simultaneous sonochemical-
enzymatic coating of medical textiles with antibacterial ZnO nanoparticles. Ultrasonics 
Sonochemistry, 2016, 29, pp 244 - 250 
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5.2.1 Introduction 
The antimicrobial finishing is a must for production of medical textiles, aiming at reducing 
the bioburden in clinical wards and consequently decreasing the risk of hospital-acquired 
infections. The production of durable antibacterial textiles embedded with inorganic 
nanoparticles (NPs) often requires time-consuming fabric pretreatments such as chemical 
or plasma activation, in addition to subsequent coating stabilization using different cross 
linking technique.318–320 Using enzymes, as tools for activation of textile surfaces, would 
avoid the use of harsh chemicals and allow to impart new functionalities to the fibrous 
substrates at mild processing conditions.321 
The objective of this work is to combine biocatalysis and physicochemical processing in a 
single-step, industry-attractive technology for durable coating of medical textiles with 
antibacterial NPs. The coating consists in embedding of ZnO NPs onto cotton fabrics in a 
30 min simultaneous sonochemical/enzymatic process. The ultrasound (US) is employed to 
boost the rate of the enzymatic (cellulase) hydrolysis and create on the cotton surface a 
larger number of reducing sugar ends for better NPs adhesion and durability of the 
antibacterial effect. The activity of the fabrics is evaluated against the clinically relevant 
bacteria Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) after multiple 
washing cycles with a non-ionic detergent at hospital laundry regimes (75 °C). 
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5.2.2 Cellulase activity at the processing conditions 
Cellulases catalyze the hydrolysis of 1,4-β-glucosidic bonds in cellulose substrates. These 
enzymes are widely used in the textile industry to reduce the surface hairiness and improve 
the evenness of cotton fabrics in a process called biopolishing. During this process, and as 
a result of cellulose hydrolysis, novel reducing sugar ends appear on the fibers surface 
providing anchoring points for further functionalization. The efficiency of the activation 
process depends on the mass transfer from the processing liquid towards the surface of the 
textile material, usually intensified by high level of mechanical agitation.322,323 It was 
demonstrated that controlled US accelerates this mass transfer without damaging the fibers, 
and results in better uniformity of the enzymatic treatment over a shorter period of time.324 
Thus, to illustrate the surface effect of the simultaneous US-enzymatic treatment, the 
morphology of the fibers after 30 min of sonication (amplitude 35 %, intensity 17.30 W/cm2, 
55 °C) alone and in presence of cellulase was observed via HRSEM. The biopolishing effect 
of the cellulase in terms of removal of the protruding after the US treatment fibrils (Figure 
5.8A) was confirmed in Figure 5.8B. 
 
 
Figure 5.8 HRSEM image of cotton fabrics after 30 min of US irradiation (amplitude 35 %, intensity 
17.30 W/cm2, 55ᵒC) in absence (A) and presence (B) of enzyme. 
Thereafter, as a prerequisite for efficient enzymatic activation of the fabric surface, we 
studied the cellulase activity as a function of the temperature and the enzyme stability in the 
ultrasonic field. The temperature profile of cellulase activity at temperatures ranging from 20 
to 65 ºC showed a maximum at 55 °C (Figure 5.9A). 
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During US irradiation free hydroxyl and hydrogen radicals created by the high localized 
pressure and temperature could inactivate the enzyme.325 To verify whether the cellulase 
activity would be affected by the US applied in the sonochemical coating process, an 
aqueous cellulase solution without substrate was exposed for 30 min to US irradiation at 
different temperatures. Thereafter, filter paper samples were incubated with aliquots of this 
solution, and the amount of reducing sugars was determined. The residual enzyme activity 
was calculated as a percentage of the activity of the enzyme not exposed to US irradiation. 
Only 10 to 20 % activity loss was detected after the US treatment regardless of the 
temperature in the cell (Figure 5.9A), suggesting that the simultaneous sono-enzymatic 
process would be feasible without compromising significantly the activity of the enzyme. 
 
 
Figure 5.9 Temperature profile of cellulase (Kappacell ETU 39) activity (A) and the residual cellulase 
activity after 30 min of US irradiation (amplitude 35 %, intensity 17.30 W/cm2) as a function of 
temperature (B). The residual activity was calculated as a percentage of the activity of the enzyme 
not exposed to US at 55 °C for 1 h in presence of Whatman No. 1 filter paper as a substrate. 
 
The hydrolytic potential of the cellulase used in our experiments was studies under 
ultrasonic irradiation with different amplitudes/intensities. Figure 4.10 compares the final 
reducing sugar concentrations after 30 min of enzymatic hydrolysis on a model cellulose 
substrate at various amplitudes. The highest amount of reducing sugars released during the 
enzymatic process was obtained when the US amplitude and intensity were 35 % and 17.30 
W/cm2, respectively.  Thus, all further experiments were carried out at these conditions, 
considered as the optimal for the enzyme performance in presence of US irradiation.  
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Figure 5.10 Reducing sugars released under different US amplitudes after 30 min of US irradiation 
at 55 °C in presence of Whatman No. 1 filter paper as a substrate. The US amplitudes of 20, 25, 30, 
35 and 40 % correspond to the US intensities of 6.90, 10.40, 13.10, 17.30 and 30.80 W/cm2, 
respectively. 
 
Thereafter, the enzyme activity at the selected processing conditions (amplitude of 35 % 
and  intensity of 17.30 W/cm2) in terms of reducing sugars released during the 30 min 
sonication process in the presence of filter paper substrate (0.5 g) was determined and 
compared to the activity of the enzyme upon mechanical stirring (110 rpm). The assay was 
performed at the temperature of maximum enzyme activity (55 °C), used further for the 
enzyme/US coating of cotton with ZnO NPs. A 3-fold increase of the released reducing 
sugars, and thus, cellulase activity, was observed upon sonication (0.311 ± 0.01 mg/mL) in 
comparison to mechanical stirring (0.096 ± 0.02 mg/mL), due to the intensified mass 
transport.324 In addition, changes in the molecular structure of the enzyme reported by others 
326 to explain its increased activity were not observed in the fluorescence spectra of cellulase 
before and after sonication (Figure 5.11). 
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Figure 5.11 Intrinsic fluorescence spectra of untreated (black chart line) and ultrasound treated for 
30 min cellulase (gray chart line). 
 
 
5.2.3 Simultaneous sonochemical/enzymatic coating of cotton with ZnO NPs 
Cotton fabrics were coated with antibacterial ZnO NPs in a simultaneous enzyme/US 
process carried out with both active and denatured enzyme as a control. ICP - AES 
measurements were further performed for quantifying the amount of ZnO on the treated 
fabrics (Table 5.2). Similar amount of ZnO was deposited sonochemically in the processes 
using either active or denatured cellulase. In addition to determining the amount of ZnO NPs 
embedded onto the fabrics, we also examined the durability of the coatings subjected to 10 
washing cycles at 75 °C in presence of non-ionic surfactant. The fabrics treated with the 
active enzyme resisted better the applied washing cycles, though ~67 % of the initially 
deposited ZnO were removed after the washings. At the same time, 95 % of the ZnO on the 
fabrics coated in presence of denatured enzyme was washed-off. Greater resistance to 
washings of the NPs on the samples treated with active enzyme demonstrates the 
significance of the enzymatic activation of the fibers surface for improved NPs adhesion and 
more durable treatment. The hydrolytic bio-treatment of the cotton fibers generates free 
hydroxyl groups on their surface, serving as anchoring points for NPs deposition.141  
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Table 5.2 Amount of ZnO deposited on the cotton fabrics in a simultaneous sono-enzymatic process 
(experimental error ± 10 %). 
Sample ZnO, % wt (per 100 g of 
fabric) after coating 
ZnO on the fabrics 
after 10 washing 
cycles (%) Non-washed Washed 
Enzyme 0.8048 0.2690 33.4 
Denatured enzyme 0.8533 0.0428 5.0 
 
 
The HRSEM surface analysis of the coated samples showed that NPs agglomeration was 
observed regardless of the enzyme used in the coating process (active or denatured). 
However, the tendency of the particles to form aggregates was more pronounced for the 
fabric coated in presence of denatured protein (Figure 5.12A, B). More uniformly distributed 
NPs were observed on the cotton surface coated in presence of active cellulase (Figure 
5.12E, F). This was additionally confirmed from the size histograms of the NPs deposited 
on both fabrics (Figure 5.13A, B), showing more narrow distribution of the deposited NPs 
when the active enzyme was used. These observations corroborate our previous findings 
that the enzymatic activation of cotton surface leads to uniformly dispersed along the fibers 
NPs.141 In the current study a similar effect was achieved using a single-step sono-enzymatic 
process. The morphology of the fabrics treated in presence of denatured and active cellulase 
after subjecting to 10 washing cycles is shown in Figure 5.12C, D and Figure 5.12G, H, 
respectively. On the surface of the fabric coated in presence of denatured enzyme few NPs 
were found after the washings, while still a dense NPs layer is observed on to the surface 
of the enzyme treated samples. These observations were in a good agreement with the ICP 
– AES findings (Table 5.2), namely NPs improved stability when deposited in a simultaneous 
sono-enzymatic process. 
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Figure 5.12 Representative HRSEM micrographs of cotton fabrics coated with 1 mM of ZnO NPs at 
55 °C in presence of denatured enzyme before (a, b) and after 10 washing cycles (c, d) and in 
presence of cellulase before (e, f) and after10 washing cycles (g, h). The images on the left were 
taken with 15000x, whereas the right-side images were taken with 50000x magnification. 
A) 
D) C) 
E) F) 
G) 
B) 
H) 
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Figure 5.13 Size histograms (fitted by Gaussian curves (solid line)) of the ZnO NPs deposited on the 
fabric in presence of denatured enzyme (a) and cellulase (b) associated with Fig. 5.12b and 5.12f, 
respectively. 
 
5.2.4 Antibacterial activity 
ZnO NPs are largely reported as efficient antibacterial agents against both Gram-positive 
and Gram-negative bacteria. The antibacterial efficiency of the fabrics coated with ZnONPs 
was evaluated against S. aureus and E. coli. The non-washed fabrics treated with active or 
denatured cellulase showed comparable antibacterial performances (~70 % reduction in 
bacteria viability) toward S. aureus (Figure 5.14a). However, after 10 washings the coatings 
obtained in presence of denatured enzyme lost entirely their antibacterial efficacy toward 
this bacterial strain. On the other hand, the coating deposited in presence of the active 
enzyme retained ~50 % of its initial antibacterial activity, which is in good agreement with 
the amount of remaining ZnO on this fabric.  
All non-washed fabrics were more efficient against E. coli, and the samples obtained in 
presence of active or denatured protein reduced the bacterial viability by 98 % and 90 %, 
respectively. After washing, however, the antibacterial performance of the coating obtained 
in presence of active cellulase was maintained. The sample coated in presence of denatured 
enzyme lost more than 30 % of its initial antibacterial efficiency (Figure 5.14b), though the 
ZnONPs amount for this sample was reduced by 95 % after the washings. A possible 
explanation for these results could be that the amount of the ZnONPs needed to inhibit the 
E. coli growth is much lower than the one initially deposited on to the fabric. On the other 
hand, the ZnO concentration on the fabrics after the washings is considerably reduced and 
it is below the concentration needed for full kill of this bacterium but still enough to inhibit 50 
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% of its growth. These findings reconfirmed that the cellulase treatment improved the 
durability of the coating effect. The higher resistance of S. aureus to ZnONPs in comparison 
with E. coli is due to the thicker peptidoglycan layer in the cell wall of Gram-positive bacteria, 
which makes them less susceptible to MeO NPs.137,327 The results also showed that the 
durability of the antibacterial effect of the ZnO NP coating obtained in the one step sono-
enzymatic coating approach against E. coli was higher compared to the already reported 
durability of the coating obtained in the two step-process (consisting of enzymatic pre-
treatment of the cotton textiles followed by sonochemical deposition of ZnO NPs).141 
 
      
Figure 5.14 Antibacterial activity of the fabrics coated with 1 mM of ZnONPs: light gray bars represent 
non-washed fabrics, whereas dark gray bars show the antibacterial activity of the fabrics after 10 
washing cycles at 75°C. The assays were performed with S. aureus (a) and E. coli (b), after 1 h of 
contact with the fabrics. 
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5.2.5 Conclusions 
Novel industry-attractive technologies are required for the manufacturing of antibacterial 
medical textiles used to reduce the risk of hospital-acquired infections. In this study we 
assessed the feasibility of a single-step sono-enzymatic process for durable coating of 
cotton fabrics with antibacterial ZnO NPs. The coating procedure resulted in the uniform 
multilayer deposition of ZnO NPs onto the fibers. As a consequence of the boosted cellulase 
activation of the fabric surface during sonication, the adhesion of the coated NPs was 
improved and thus, the antibacterial performance was ensured. Although the outer NP 
layers were not firmly fixed on the textiles, 33 % of the initially deposited ZnO NPs remained 
on the surface after multiple intensive washing cycles. The remaining after washings NPs 
still exhibited nearly 100 % reduction of the viability of E. coli, whereas the efficiency toward 
S. aureus decreased by 50 %. In summary, the one-step sono-enzymatic process is an 
attractive alternative to the currently used technologies for antibacterial textile 
functionalization that rely on aggressive and time-consuming chemical pre-treatments to 
achieve durable antimicrobial fabrics. 
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5.3 Enzyme-assisted functionalization of cork surface with antibacterial 
biopolymer/silver hybrid nanoparticles 
 
 
 
This section is based on the following publication:  
Francesko A, Blanón L, Vázquez M, Petkova P, Morató J, Pfeifer A, Heinze T, Mendoza E, Tzanov 
T, Enzymatic functionalization of cork surface with antimicrobial hybrid biopolymer/silver 
nanoparticles. Applied Materials & Interfaces, 2015, 7(18), pp 9792-9799 
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5.3.1 Introduction 
In this work, antibacterial silver nanoparticles (AgNPs) colloidal dispersions were 
synthesized by reduction of silver nitrate (AgNO3) with sodium borohydride (NaBH4) and 
simultaneously doped with two amino-functional biopolymers: CS and AC. In this reaction 
the chemical reagent can be omitted because both chitosan (CS) and aminocellulose (AC) 
have been used as combined reducing and capping agents.328,329 However, NaBH4 is used 
as a fast reducing agent in order to avoid high temperatures in the reaction and/or the 
assistance of an additional technology required for the Ag+ reduction.  
The employment of CS and AC is considered advantageous for stabilization of the AgNPs 
providing in the same time the particles with amino functionalities for immobilization on 
different solid substrates and thus, facilitating the NPs recovery and reuse.  
Herein, laccase-assisted oxidation of the phenolic structures in cork is used to covalently 
immobilize the hybrid biopolymer-AgNPs on the cork surface via reaction with the amino 
groups in biopolymers. The antimicrobial activity of the green-functionalized cork is 
evaluated against E. coli and S. aureus, in order to assess its potential as a filter to reduce 
these common pathogenic indicators of pollution in constructed wetlands.   
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5.3.2 Characterization of AgNPs and AgNPs-biopolymers dispersions  
AgNPs were synthesized by a chemical reduction of AgNO3 with NaBH4 in absence and 
presence of biopolymers. In order to confirm the interactions between CS and AC with 
AgNPs during their synthesis, the ζ potential of pure AgNPs and biopolymer-doped AgNPs 
was measured. AgNPs doped with biopolymers displayed positive ζ potential values due to 
the presence of amino groups in the macromolecules that are protonated at pH 5 – used for 
the AgNPs preparation (Table 5.3). Given that pure AgNPs display a negative potential, 
these results suggest the interactions between the AgNPs and the biopolymers. 
The pure AgNPs also displayed notably smaller hydrodynamic radius than their homologues 
doped with biopolymers (Table 5.3). When measured by DLS, the increase in the NPs 
diameter in presence of biopolymers represents an indirect demonstration that the AgNPs 
are coated with macromolecules in thick layers.184 This is the opposite to a thin layer doping 
of noble metal NPs in which case the change in the hydrodynamic radius is negligible.10 
Also, in our study it is probable that the similar Mw of the biopolymers used induced 
comparable size increase after the AgNPs doping.  
 
Table 5.3 ζ potential and mean hydrodynamic radius of AgNPs synthesized in absence and presence 
of CS and AC. 
Sample ζ potential (mV) Mean particle size (nm) 
AgNPs -25.3 ±  0.8 32.3 ± 1.7 
AgNPs-CS 41.5 ± 0.7 239.6 ± 13.5 
AgNPs-AC 26.2 ± 1.36 253.8 ± 20.0 
 
The interactions between the AgNPs and biopolymers were further confirmed by STEM 
analysis. Without doping the AgNPs were abundant in the dispersion and most of the 
particles displayed the sizes ≤30 nm (Figure 5.15A). In contrast, the average sizes of the 
AgNPs doped with CS or AC, which were shaped in rod-like structures, exceeded 100 nm, 
thereby confirming the DLS findings (Figure 5.15B and C). The doped particles were well 
dispersed in the biopolymer templates forming aggregated complexes, apparently as a 
result of their sticking upon drying of the sample. The pure AgNPs precipitated in a matter 
of hours leaving very few particles in the dispersion (Figure 5.15D). This is expected since 
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the synthesis of NPs by strong chemical reduction often results in agglomeration and 
precipitation of the colloids. In contrast, the hybrid structures of the biopolymer-doped 
AgNPs were stable and resisted the aggregation in dispersion and precipitation (Figure 
5.15E and F). STEM images together with the macroscopic observation of the dispersions 
(inset images) provided a clear proof that both CS and AC stabilized the AgNPs dispersions 
through the passivation of the particles surface.  
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Figure 5.15 STEM images of the AgNPs dispersions synthesized in absence and presence of CS and AC. The images were taken to evaluate the 
presence of NPs in the dispersions immediately after the synthesis of the particles (images A, B and C) and after 3 h of their preparation (images D, 
E and F). The inset photographs represent the analyzed dispersions.
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UV-Vis spectra were recorded for the pure AgNPs and the dispersions doped with CS and 
AC after 72 h of their synthesis. Since the dispersion prepared in absence of biopolymers 
was unstable and entirely precipitated during this time leaving the above solution clear, no 
characteristic for AgNPs absorption is observed in its spectrum in the 300-500 nm range 
(Figure 5.16). In contrast, the SPR band was detected for the stable AgNPs dispersions 
prepared in presence of both CS and AC. The change in color of the dispersion and the 
consequent appearance of the bands between 400 nm (for AgNPs-AC) and 425 (for AgNPs-
CS) implies the interaction between the biopolymers and AgNPs surface which modify their 
interaction with light.330 
Besides the different wavelength position of the SPR peak, the intensity of AgNPs-AC was 
around 3 times higher than that of AgNPs-CS. The intensity of the band in the AgNPs 
systems where biopolymers are used as particle stabilizers varies as a function of the 
preparation conditions, as well as the amount of a biopolymer used for the particles doping. 
Nevertheless, despite the higher peak intensity of the AgNPs-AC system and the same 
starting concentrations of AC and CS, it still could not be concluded that this macromolecule 
interacts better with silver compared to CS, especially in the case where the reduction of 
Ag+ to elemental silver solely depends on the chemical compound (NaBH4). Although the 
peak intensities are directly proportional to the amount of the AgNPs-biopolymer hybrids, 
these can only be compared between different samples of the same system (obtained 
varying the preparation conditions). For example, certain biopolymer concentrations can 
decrease the silver particles surface exposure to light, which may be the reason for decrease 
or even the absence of the SPR band in such systems.331 If such scenario is applied to our 
case, we may even speculate on a better coverage of the AgNPs surface by CS compared 
to AC due to their strong interactions. Nevertheless, the strength of the organic-inorganic 
interactions as a function of the biomaterial structure goes beyond the scope of this 
manuscript.    
Important from the technological point of view, the uniform color distribution throughout both 
AgNPs-CS and AgNPs-AC dispersions means that these hybrid systems were uniformly 
distributed in the dispersions, which broadens their application potential and facilitates 
exploitation of their functional properties. In addition, no precipitation was observed during 
several weeks after their synthesis, revealing sufficient stability of the systems for e.g. further 
surface functionalization of different materials. 
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Figure 5.16 UV-Vis spectra obtained for the pure AgNPs dispersion and the dispersions doped with 
CS and AC after 72 h of their synthesis. 
 
5.3.3 Enzymatic grafting of hybrid biopolymer-AgNPs on cork 
The characterization of the AgNPs and hybrid biopolymer-AgNPs using ζ potential, DLS, 
UV-Vis and STEM analysis, indicated that interactions between the particles and CS or AC 
occur. Doping of the AgNPs with these biopolymers provides the amino moieties on the 
particles surface necessary for the enzyme-catalyzed covalent immobilization of NPs onto 
cork. The used enzymatic immobilization approach is complex and may involve different 
interactions/reactions between the cork surface and used macromolecules, such as 
electrostatic interactions, hydrogen bonding and covalent linking between the laccase-
activated cork moieties and CS or AC. In this work we targeted covalent bonding in order to 
permanently functionalize the cork surface with biopolymer-doped AgNPs using laccase-
assisted immobilization which necessarily comprises: i) oxidation of the cork phenol groups 
(from suberin and lignin) to reactive quinones, and ii) reaction of the quinones with 
nucleophilic moieties (amino groups) in biopolymers through 1,4-Michael addition or Schiff 
base formation,332 as illustrated on Scheme 5.1. 
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Scheme 5.1 Mechanism of immobilization of the hybrid AgNPs-biopolymers onto cork. Mechanisms above the scheme, show two possibilities of 
reaction: (1) Michael addition, (2) Schiff base formation. 
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FTIR spectra were recorded to verify whether the functionalization of the cork surface was 
successful. Prior to analysis, unmodified cork, cork enzymatically treated with pure AgNPs 
(immediately after their preparation) and cork treated with the hybrid biopolymer-AgNPs 
were subjected to thorough washing during which the samples were immersed in distilled 
water and vigorously stirred for 5 days. The water was changed each 24 h and the remaining 
solutions were checked for the presence of NPs by optical microscopy using a Nikon Eclipse 
Ti microscope, with a 100x oil-immersion objective. After 4 days in water, no particles were 
detected in any of the remaining solution meaning that after this time there was no AgNPs 
leaching from the samples.  
The unmodified cork and cork treated with pure AgNPs displayed characteristic for cork 
spectra with some of the most prominent bands as markers of: i) suberin at 1462 cm-1, 1236 
cm-1 and 1157 cm-1, its aliphatic chains at 2918 cm-1 and 2852 cm-1, and its ester groups at 
1735 cm-1 and 721 cm-1, ii) lignin aromatics at 1600 cm-1, 1510 cm-1 and 849 cm-1, and iii) 
cork polysaccharides at 1096 cm-1 and 1035 cm-1 (Figure 5.17).333 Clear and comparable 
differences were found in the spectra of the cork treated with AgNPs-biopolymer hybrids. All 
peaks attributed to the cork suberin including the bands constituting the typical suberin 
fingerprint (1462 cm-1, 1236 cm-1 and 1157 cm-1)334 decreased considerably after the 
enzymatic functionalization. Also the bands representing the lignin aromatics decreased or 
completely disappeared. Thus, both suberin and lignin from cork were involved in the 
functionalization reaction. At the same time, the differences in the spectra in polysaccharide 
regions between 1532 – 1681 cm-1 and 900 – 1120 cm-1 suggest a successful biopolymer 
grafting, but this regions are rather complicated for deeper analysis. Instead, a shoulder 
peak was noticed at 1260 cm−1 in the spectra of the treated cork (especially pronounced for 
the cork treated with AgNPs-CS), which could be attributed to C-N stretching of aryl amides 
formed via Michael addition.332 Therefore, the FTIR spectra confirmed that the phenolic 
moieties from suberin and lignin in cork were covalently linked with CS or AC, where the 
reaction occurred predominantly via Michael addition. 
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Figure 5.17 FTIR-ATR spectra of untreated and enzymatically functionalized cork with AgNPs, 
AgNPs-CS and AgNPs-AC dispersions. 
 
SEM analysis was carried out in order to confirm the presence of AgNPs on the cork surface 
after the enzymatic treatment. On average, cork cells rarely exceed 50 µm height, with a 
hexagonal face of 15-20 µm and a thickness of 1-2 µm.17 SEM images were thus taken 
inside the cells, first for the untreated cork without the NPs (Figure 5.18A). The cell surface 
was not smooth and appeared granulated, where the remaining deposits, not removed 
during the cleaning procedure, were noticed. The same deposits were observed on the cork 
treated in presence of laccase with the AgNPs immediately after their synthesis (Figure 
5.18B). The AgNPs were thus not fixed on the cork surface or were removed during the 
immersion in water for 5 days. In contrast, particles and macromolecular structures were 
observed on the cork enzymatically embedded with the hybrid AgNPs-biopolymer systems 
even after extensive washing with water (Figure 5.18C and D). This was especially the case 
of AgNPs-CS treated cork, which displayed a large amount of NPs on the surface. Both 
individual submicron particles and larger agglomerates could be visualized. A lower number 
of AgNPs was observed on the cork surface treated with AgNPs-AC system (marked with 
red arrows on Figure 5.18D), but these were still fixed strong enough to resist the removal 
 97 
 
by thorough washing. A larger number of permanently deposited AgNPs was achieved via 
the laccase-assisted grafting of CS on cork.  
 
 
Figure 5.18 SEM images of cork surface enzymatically treated in absence (A) and presence of NPs: 
(B) pure AgNPs, (C) AgNPs-CS, and (D) AgNPs-AC. 
 
5.3.4 Antimicrobial activity of AgNPs-embedded cork matrices 
The antibacterial activity of cork matrices functionalized with biopolymer-doped AgNPs was 
evaluated at different time points after immersing the materials in water up to 5 days. The 
results of the time-kill experiments showed that the cork matrices treated with pure Ag-NPs 
(immediately upon their preparation) fully inhibited the bacterial growth for both E. coli and 
S. aureus if no washing procedure was performed (Figure 5.19). Although not expected in 
such extent, the antibacterial effect of cork-AgNPs sample could be explained by a moderate 
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adsorption capacity of cork towards silver.335 In contrast, other materials such as nanoclay 
have been associated with AgNPs in absence of auxiliary molecules to impart diffusion-
controlled antimicrobial activity, with long term impact.336 Adsorption of metals onto different 
sorbents may occur by physiosorption and chemisorption.337,338 Considering that the 
chemisorption involves the permanent modification through generation of new chemical 
bonds at the surface of a material and the progressive loss of the antibacterial effect of cork-
AgNPs during 5 days in water, it is logical to conclude that this material maintained the 
activity whereas the physically adsorbed particles persisted on its surface. On the other 
hand, the cork matrices functionalized with AgNPs-CS and AgNPs-AC hybrids preserved 
most of the antibacterial effect (against E. coli) or fully retained the effect (against S. aureus) 
during the extensive washing procedure. Although it is probable that some of the hybrid 
structures were also physically adsorbed on surface (reflected in somewhat lower effect of 
the cork-AgNPs-CS and AgNPs-AC in case of E. coli after 5 days of washing), these results 
indirectly confirm the FTIR and SEM findings for the permanent functionalization of cork with 
AgNPs-biopolymer hybrids using the laccase-assisted approach. 
 
 
Figure 5.19 Antimicrobial activity of untreated and enzymatically functionalized cork with AgNPs, 
AgNPs-CS and AgNPs-AC dispersions. The materials were subjected to the washing treatment in 
water (stirring 100 rpm) for up to 5 days, during which the antibacterial activity is evaluated at different 
time points. 
 
The antimicrobial effect of cork-AgNPs-CS and cork-AgNPs-AC after 5-day washing was 
also compared to the matrices enzymatically functionalized with only CS and AC (without 
AgNPs), in order to reveal if the effect of the biopolymers was restricted only to the material 
functionalization. Calculated in percentage of bacterial inhibition compared to the effect of 
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untreated cork, the matrices with enzymatically embedded hybrid AgNPs-CS and AgNPs-
AC reduced respectively by 99.6 % and 85.3 % the growth of E. coli, whereas showing the 
full kill potential in the case of S. aureus (Table 5.4). Although the SEM images showed 
more AgNPs particles immobilized on cork in the case of AgNPs-CS, the antimicrobial 
efficiency of these two materials were comparable for the used bacteria inoculums. Such 
scenario did not allow to clearly distinguish the individual effects of AgNPs on one side and 
intrinsically antimicrobial CS or AC on another. Indeed, CS is a known while AC (a more 
economical substitute of CS) is an emerging antimicrobial macromolecule in different 
forms.339,340 Cork treated with CS and AC in absence of AgNPs did not show activity against 
E. coli, whereas the efficiency for S. aureus reduction was of 10.2 % and 4.3 %, respectively. 
The antibacterial potential of these matrices is measured in the assay optimized to 
distinguish the effect of the cork embedded with AgNPs (small amount of the material and 
high bacteria count), which certainly possess higher antibacterial activity than the 
biopolymers. Thus, the absence or the low extent of the antibacterial potential of the matrices 
treated only with biopolymers is explained with the assay conditions applied. Moreover, a 
slightly higher antibacterial potential of the CS- treated compared to the matrices containing 
AC is attributed to better grafting of CS macromolecule compared to AC (concluded from 
the SEM images). Overall, the antibacterial efficiency of the cork grafted with hybrid AgNPs-
biopolymers is largely dependent on the presence of silver. Nevertheless, some synergistic 
antibacterial effect of the AgNPs and the intrinsically antibacterial amino-functional 
biopolymers could still be envisaged, though the enhancement of antimicrobial activity in 
hybrid nanoscale architectures based on silver for long-term effect is not a new concept.341  
Table 5.4 Antibacterial activity of enzymatically modified cork against Escherichia coli and 
Staphylococcus aureus after 5 days washing in water. The results are expressed in % of bacteria 
reduction compared to the untreated cork. 
 
 
Sample E. coli reduction (%) S. aureus reduction (%) 
Cork-AgNPs- CS 99.6 100 
Cork-AgNPs-AC 85.3 100 
Cork-CS 0 10.2 
Cork-AC 0 4.3 
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In order to better understand the effect of the hybrid nano-coating on the bacteria, we further 
studied (by SEM) the surface morphology of the cork granules (natural cork or functionalized 
with AgNPs-CS complex) after incubation in water inoculated with E. coli. The SEM analysis 
revealed the presence of accumulated E. coli on the cork surface (Figure 5.20). However, 
the morphology of the bacteria found on the untreated cork and on the cork-AgNPs-CS 
composite was very different. Proliferating bacteria with well-formed flagella were observed 
on the surface of the untreated cork (Figure 5.20 A, B), whereas the E. coli found on the 
functionalized with AgNPs-CS cork granules were not flagellated (Figure 5.20 C, D). 
Apparently, the hybrid nanocomposite affected the bacteria structure and could prevent their 
attachment and proliferation on the surface. More bacteria were attached on the surface of 
the unmodified cork than on the surface of the cork-AgNPs-CS composite. The loss of 
flagella in E. coli after water disinfection with TiO2-based photocatalyst was previously 
reported.342 The presence or absence of flagella is important to bacterial survival and growth, 
since these appendages are not only driving cell locomotion, but also allow the bacteria to 
attach to surfaces or to epithelial cells.343 It is well established that flagellar-mediated motility 
and the ability to produce a number of pili are essential for biofilm formation 344 and contribute 
to the virulence of pathogenic bacteria.345  
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Figure 5.20 SEM images of E. coli accumulated on the surface of unmodified cork (A, B) and on the 
CS/AgNPs-cork composite (C, D) after 16 h of contact with E. coli suspension. The images on the left 
were taken with 10000×, whereas the right-side images were taken with 100000× magnification. 
 
 
As a next step, the viability of the bacteria accumulated on the cork surface was tested by 
placing the cork pieces on Coliform agar plates specific for E. coli. The results showed that 
the flagellated bacteria observed on Figure 5.20A and B on the surface of the unmodified 
cork samples were viable, while bacteria growth was not observed for the cork-AgNPs–CS 
samples on which surface the bacteria were without flagella (Figure 5.21D). Therefore, the 
bacteria found observed on Figure 5.20 C and D were not viable, demonstrating the 
disinfection potential of the designed material. 
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Figure 5.21 Images of natural cork granules after incubation in sterile distilled water (A) and water 
inoculated with E. coli (B); and cork-AgNPs-CS composite after incubation in sterile distilled water (C) 
and water inoculated with E. coli (D) for 16 h at room temperature. The images B and D are related 
to Figure 5.20 A, B and Figure 5.20 C, D, respectively. 
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5.3.5 Conclusions 
In this study, the laccase oxidation of the phenol moieties in cork into reactive quinones and 
their further reaction with nucleophilic amino groups in CS- or AC-doped AgNPs was 
exploited to impart durable antibacterial activity onto cork matrices. The role of CS and AC 
biopolymers in the hybrid NPs structures was three-fold in order to: (i) stabilize the AgNPs 
and prevent their aggregation, (ii) serve as an interface for permanent grafting of AgNPs on 
cork, and iii) synergistically improve the AgNPs antibacterial effect. The biocatalytically 
functionalized cork matrices with AgNPs-CS and AgNPs-AC efficiently reduced the 
Escherichia coli and Staphylococcus aureus growth during the course of 5 days. Such long-
term stability and durability of the antimicrobial effect in conditions of continuous water flow, 
suggest the potential application of the functionalized cork matrices in constructed wetlands 
as an adsorbent for removal of wastewater impurities at the same time avoiding microbial 
contaminations. 
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5.4  Enzyme-assisted formation of nanoparticles-embedded hybrid 
biopolymer hydrogels for wound healing 
 
 
 
This section is based on the following publication: 
Petkova P, Francesko A, Tzanov T., Enzyme-assisted formation of hybrid biopolymer hydrogels 
incorporating active phenolic nanospheres., Engineering in Life Sciences, 2015, 15 (4), pp 416–424 
  
 105 
 
  
 106 
 
5.4.1 Introduction 
This study reports on the synthesis of hybrid nanocomposite hydrogels comprising a 
thiolated chitosan (TC) platform that incorporates epigallocatechin nanospheres (EGCG 
NSs) as active polyphenolic agents for wound healing applications. The phenolic 
nanospheres (NSs) were prepared using an industry-attractive, low-cost and fast 
sonochemical technology, whereas the gel formation was achieved via a green approach 
involving the enzymatic cross-linking with horse-radish peroxidase (HRP), avoiding the use 
of chemical cross-linkers. In the hybrid material, the EGCG NSs will integrate the structural 
role to reinforce the hydrogel network with the healing function in chronic wound therapy. 
The chronic wound environment is normally colonized with bacteria,346 and characterized 
with high concentrations of reactive oxygen species (ROS) and elevated levels of 
(myeloperoxidase) MPO and collagenases, that altogether impair the normal wound healing 
process. Thus, the NSs functional properties will be evaluated for their potential to inhibit the 
chronic wound enzyme (MPO and collagenase) activities and their antibacterial and 
antioxidant properties prior to their loading into the TC matrix. The NSs release profile from 
the hybrid hydrogel material and the cytotoxicity of the system to human foreskin fibroblasts 
will be also assessed. 
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5.4.2 Nanospheres preparation and characterization  
Some of the most common techniques used to prepare biodegradable NPs (nanospheres 
and nanocapsules) however the selection of an appropriate route depends on different 
factors including the particle size, their thermal, chemical and physiological stability, and the 
requirement of an organic solvent and surfactants in the reaction, both being associated with 
the biocompatibility of the final product. The EGCG NSs were prepared by ultrasound 
technology as this is surfactant free method for designing of nano/micro-scale materials due 
to the rapid reaction rates, relatively uniform size distribution and high purity of the obtained 
particles.347 Moreover, the sonochemistry has been successfully applied for formation of 
various polymeric micro- and nano-spheres without compromising the intrinsic functional 
properties.340 These structures may serve as bioactive compound itself or can encapsulate 
various drugs.  
The cumulant (Z-average) hydrodynamic size of the sonochemically generated EGCG NSs 
(Scheme 5.2) was measured by DLS and was found to be 270±21 nm (Figure 5.22A). The 
results showed that the obtained NSs suspension is monomodal (only one peak), spherical 
(Figure 5.22B) and with PDI of 0.044±0.007 considered monodisperse (PDI < 0.1).348 
 
 
Scheme 5.2 Sonochemical synthesis of EGCG NSs preparation and their purification. 
Centrifugation 
(NSs purification) 
Ultrasound 
Organic 
solvent 
Aqueous solution of polyphenols 
Mixture organic 
solvent/NSs 
Organic 
solvent 
 108 
 
 
Figure 5.22 Data of EGCG NSs hydrodynamic radius (at 25 ° C) (n=3) (A), and fluorescence 
microscopy image of the spheres filled with Nile red (B). Scale bar 2 µm. 
 
The obtained phenolic NSs were further studied for their suitability for application as active 
compounds for chronic wounds management. To this end, their antibacterial properties, 
antioxidant capacity and ability to inhibit MPO and collagenase enzymes were evaluated 
prior to the inclusion into biopolymer hydrogels. 
 
5.4.3 Inhibition of chronic wound enzymes 
The capacity of the NSs and the EGCG in solution to inhibit MPO (the anti-inflammatory 
potential) and collagenase (the antiprotease capacity) activities was studied. The EGCG 
NSs showed higher anti-inflammatory activities in comparison with the EGCG in solution 
(Figure 5.23A). As expected, more diluted EGCG solutions/NSs suspensions displayed 
lower inhibition capacities compared to more concentrated ones. Nevertheless, the NSs in 
the lowest concentration tested (0.001 mM) still inhibited nearly 50 % of the MPO activity, 
whereas at the same concentration the EGCG solution did not inhibit the enzyme. The same 
tendency was observed in the study evaluating the ability of EGCG NSs and solution to 
inhibit collagenase. In all tested concentrations the NSs showed better properties compared 
to the EGCG solution (Figure 5.23B). The highest concentration of polyphenolic NSs (0.5 
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mM) displayed close to 100 % inhibition. The higher enzyme inhibition capacity of the EGCG 
NSs compared with the one of the EGCG in free form could be explained by occluding the 
enzyme active site substrate entrance by the NSs.349 Additionally, the high surface to volume 
ratio, i.e. large surface area of the NSs allows a better contact of the structures with the 
enzyme active site.350 Comparing between the two enzymes, the inhibition of collagenase 
activity required higher concentrations (or less dilution) of both EGCG NSs and free solution 
by nearly 70 fold (the IC50 values for MPO and collagenase were 0.001 mM and 0.07 mM, 
respectively), already noticed in our previous work.246 
 
 
 
Figure 5.23 Functional properties of EGCG NSs (light grey bars) and free solution (dark grey bars). 
Inhibition of the activity of MPO (A) and collagenase (B). All results are reported as mean values ± 
standard deviation (n=3). 
 
The activity of proteases in normal wounds is tightly regulated at the cellular level by the 
controlled expression of protease inhibitors. A failure at any level of this control mechanism 
would result in an increase in proteolytic activity, a trait of chronic wounds. The acute and 
chronic wound fluids biochemical and molecular profiles are different, where chronic wounds 
contain high levels of MPO, and proteolytic matrix metalloproteinases (MMPs), with the most 
abundant being collagenases. In the persistent inflammatory environment the MPO-
generated hypochlorous acid (HOCl) oxidizes most biological molecules, adversely affecting 
the tissue regeneration. In addition, HOCl also triggers the MMPs activation351 to further 
contribute the tissue deterioration. Therefore, the chronic wounds treatment should include 
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control over MPO and MMPs activities (total inhibition is not required), in order to provide 
favorable for the healing and extracellular matrix reconstruction conditions.  
The current therapies aiming to modulate the activity of major chronic wound enzymes 
involve the application of anti-inflammatory agents as persistent inflammation is often a key 
to impaired wound healing. Alkaloids,352 plants polyphenol extracts,353 synthetic polymers 
with hydroactive properties,354 oleic acid355 and peptides356 are therapeutic agents that 
through different mechanisms stimulate healing of chronic wounds. In the most recent 
attempts, chitosan and collagen based dressings were previously upgraded with bioactive 
phenolic compounds to simultaneously control MPO and collagenase activities in vitro.246,278 
 
5.4.4 Radical scavenging activity 
The DPPH assay was used to study the antioxidant capacity of EGCG NSs and EGCG in 
solution. In contrast to the inhibition of enzymes, no differences in the radical scavenging 
activities between NSs and free solution were observed (Figure 5.24). The antioxidant 
properties of phenols are linked with their chemical structure as their efficiency increases 
with increasing the number of OH groups. In the case of nano-scaled materials radical 
scavenging activity depends on a surface reaction since only the surface comes in contact 
with the free radicals.357 Thus, our results suggest that the amount of phenolic groups is 
similar in the NSs and free solution, meaning that these are not involved in the sonochemical 
stabilization of the nanospheres. The latter was confirmed by evaluating the total phenol 
content, which was 0.176 ± 0.006 and 0.173 ± 0.004 mM GAE, respectively for the EGCG 
NSs and free solution. In addition, the surface contact with the functional groups is probably 
not crucial in the case of DPPH scavenging, as in the case of the enzyme inhibition. 
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Figure 5.24 The antioxidant activity of EGCG NSs (light grey bars) and free solution (dark grey 
bars). All results are reported as mean values ± standard deviation (n=3). 
 
5.4.5 Antibacterial activity 
The loss of skin integrity and the exposure of the cutaneous tissue in chronic wounds provide 
a favorable environment for bacteria to colonize and proliferate. The antimicrobial activity of 
the NSs suspension/solution was therefore evaluated against the Gram-positive S. aureus 
- being one of the most commonly found pathogen in chronic wounds associated with 
changes to wound healing times.358 
The results demonstrated that the EGCG NSs have better antibacterial performance than 
free solution, for all tested dilutions (Figure 5.25). Whereas the highest concentrations of 
NSs and free solution showed comparable antibacterial properties, their dilution led to 
different behavior in terms of inhibition of the S. aureus growth. The NSs displayed no 
changes in their performance down to 0.1 mM, whereas the EGCG solution did not show 
any antibacterial capacity at this concentration. The better antibacterial performance of the 
EGCG NSs could be attributed to the improved biophysical interactions between the NSs 
and bacteria including the NSs biosorption and bacterial uptake.359 It has been also reported 
that the size and shape of the NPs could affect their antibacterial performance, usually 
following the rule that smaller structures of spherical shape are better antibacterials than 
bigger NPs with elongated shapes.350 The small size of the NPs and the high surface to 
volume ratio aid to their interaction with the bacteria and the enhanced antimicrobial 
potential. 
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Figure 5.25 The antibacterial activity of EGCG NSs (light grey bars) and free solution (dark grey 
bars) towards Staphylococcus aureus. All results are reported as mean values ± standard deviation 
(n=3). 
 
5.4.6 Enzyme-assisted hydrogel formation 
The hydrogel preparation was achieved via HRP-mediated coupling reaction of thiol groups 
in TC (serving as a nucleophile) in presence and absence of phenolic NSs (Scheme 5.3). 
The ability to control the gelation time by varying the concentration of H2O2 used in the 
reaction was demonstrated regardless of the EGCG NSs presence (Figure 5.26). As 
expected, the gelation times decrease from 660 to 46 sec and 420 to 23 sec in presence 
and absence of NSs respectively, as the H2O2 concentrations increase from 0.05 wt % to 
1.0 wt %. After the addition of HRP and H2O2, the thiols are susceptible to oxidization and 
are coupled to each other to give disulfide (-S-S-) bonds. The system consists of two 
interdependent reactions: the HRP/H2O2 mediated oxidation of thiols to thiyl radicals and 
later non-enzymatic transformation of these radicals to disulfides.360 
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Scheme 5.3 EGCG NSs loading into TC hydrogels. 
 
Oil core 
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Figure 5.26  In situ gel formation of TC/EGCG hydrogels in the presence of HRP (9.65 U/mL) and 
different concentrations of H2O2. Data of the mean time of gelation ± standard deviation (n=3) are 
reported. 
 
To study the behavior of the thiolated chitosan hydrogels when placed in aqueous 
environment, their swelling and degradation properties prior the NSs inclusion were 
evaluated. The swelling capacity of the TC hydrogels revealed that half of the total water 
uptake was absorbed within the first hour (34 %), while the swelling progressively continued 
reaching 66 % after 24 h, and then increased slowly to its maximum of 74 % at day 3 (Figure 
5.27A). The results for hydrogel degradation indicated that after 3 weeks the hydrogels only 
lost ~25 % of their initial weight (Figure 5.27B). The weight loss was more pronounced during 
the first week as the weight of the samples decreased by 15 %, suggesting that during this 
period the non-cross linked polymer is released into the aqueous medium. When a hydrogel 
material is placed in an aqueous solution, water molecules penetrate into the polymer 
network. The water molecules are expected to occupy the free space in the network meshes, 
which will start to expand, allowing other water molecules to enter. The most important 
parameters influencing the biopolymer constructs swelling and stability are the hydrophilicity 
of its constituents and the extent of cross-linking in the matrix. 
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Figure 5.27 TC hydrogels swelling ratio (A) and degradation (B). The results show the mean hydrogel 
swelling and degradation of each experimental group ± standard deviation (n=6 for each time point). 
 
The oxidative enzymes, such as the HRP, can also convert phenol groups in the EGCG to 
reactive quinones, which subsequently undergo non-enzymatic reactions with a variety of 
nucleophiles including the available free thiols and/or amino groups. It is generally accepted 
that the phenolic compounds are promoters of the peroxidase-catalyzed thiol oxidation by 
reducing the rate-limiting HRP intermediate and/or by oxidation of thiols by free radicals of 
phenols.360,361 It was therefore expected that in presence of phenolic NSs, the enzyme-
mediated gelation will be faster in comparison with the control (absence of phenolic NSs). 
Instead, the time of gelation increased with the nanospheres inclusion (Figure 5.26). The 
conventional peroxidase cycle involves reaction with H2O2, which is reduced to water while 
phenols are oxidized to phenoxy radicals that dimerize. On the other hand, when the thiols 
are oxidized by peroxidases (reactions characterized with the oxygen consumption) the 
process is yielding H2O2. The higher the concentration of H2O2 is, the more decomposition 
of H2O2 and more thiyl radicals are produced. The additional production of the oxidizing 
agent (H2O2) during the -S-S- bonds formation could be the reason why the gelation time in 
absence of phenols (which will reduce the H2O2 concentration) is faster.360 Similarly to the 
findings reported by Sakai et al. (2014), namely decreased gelation time with decreasing of 
phenol groups content of chitosan/phenol system, was observed in our case by addition of 
the phenol NSs formulations of lower concentrations (Table 5.5).362 
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Table 5.5 Hydrogels time of gelation at room temperature using horseradish peroxidase (9.65 
U/mL) and different concentrations of hydrogen peroxide and EGCG NSs:TC ratios. 
EGCG NSs:TC ratio (v/v) H2O2 concentration (%) Time of gelation (sec) 
1/99 0.3 83 
10/90 0.3 150 
1/99 0.5 60 
10/90 0.5 90 
 
 
5.4.7 Hydrogel morphology 
The SEM of the inner section of the hydrogels loaded with the EGCG NSs confirmed the 
spheres incorporation into the material. The NSs were also intact after their incorporation 
into the gel matrix (Figure 5.28). The presence of a few bigger than 1 µm NSs is probably 
due to the nanospheres aggregation (Figure 5.28B, inset image). 
 
 
 
Figure 5.28 Hydrogels morphology (A) TC and (B) TC hydrogels loaded with EGCG NSs. 
 
5.4.8 In vitro release study 
After being loaded into the TC hydrogels, the EGCG NSs release profile from the biopolymer 
matrices was studied. The results (obtained after measuring the turbidity of the incubation 
solution) showed a potential of the obtained hydrogels for the sustained delivery of the intact 
A B 
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EGCG NSs. Nearly 50 % of the incorporated EGCG NSs were released during the course 
of 6 days in close to linear regime (Figure 5.29). The evaluation period of 6 days was chosen 
as a maximum and desirable period for the wound dressing change. Beyond this time the 
cells at the wound bed strongly adhere and proliferate within the material, which would 
impede the dressing removal.363 On the other hand, the lower frequency of dressing change 
is costly while the strategy to maintain the environment moist in order to facilitate the wound-
healing process through prevention of tissue dehydration and cell death is compromised. 
Moreover, the extent of the enzyme inhibition could be easily controlled by applying the 
hydrogel dressing on the wound site for different time periods. 
 
 
Figure 5.29 Time-dependent release of EGCG NSs from TC hydrogels. Three samples were 
evaluated for each time point and data are reported as mean EGCG NSs release (%) ± standard 
deviation. 
 
5.4.9 Cytotoxicity 
There is a notable rise in the number of publications discussing the toxicity of nanomaterials, 
based on their size, safe dose administration, and material constituents. Hence, the 
evaluation of their biocompatibility properties is highly recommendable, especially when 
such materials are aimed for medical applications. Thus, the toxicity of TC, EGCG NSs and 
their mixture to human foreskin fibroblasts cell line was assessed. All materials displayed 
good biocompatibility (above 90 % compared with the control), indicating that the application 
of the generated hydrogels as drug delivery devices would be safe (Figure 5.30). 
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Figure 5.30 Cytotoxicity of EGCG NSs, TC and their mixture to human cell fibroblasts. The results 
show the mean cytotoxicity values of 3 independent assays ± standard deviation (n=6). 
 
CS is a nontoxic polymer and widely applied as a drug delivery material. In addition, EGCG 
has been reported to have high antitumor activity,364 and also ability to protected human 
normal bronchial epithelial BEAS-2B cells from Cr(VI)-induced cell death and apoptosis.365 
However, it was also reported that low concentrations of EGCG have inhibited the DNA 
damage induced by reactive oxygen and nitrogen species, while higher concentrations of 
the compound may itself result in damage to cellular DNA.366 The EGCG conjugation with 
other materials (as in our case) is also a way to reduce its harmful effect.367  
 
 
 
 
 
 
 
 119 
 
5.4.10 Conclusions 
EGCG nanospheres were successfully generated via a one-step sonochemical process and 
further incorporated into the TC hydrogel platforms prepared by enzyme-mediated gelation 
without compromising the particles integrity. By optimizing the H2O2 concentration, the 
enzymatic gelation can be controlled to occur within less than 1 min. The potential of the 
phenolic NSs as chronic wound healing promoters was demonstrated via the improved 
antibacterial and chronicity factors inhibition compared to the EGCG in solution. Moreover, 
the intact EGCG NSs were released from the highly biocompatible hybrid hydrogel in a 
sustained manner over 6 days, suggesting potential for prolonged usage and low frequency 
of dressing change for wound healing applications.  
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6 Final conclusions 
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A range of multifunctional nano-structured materials aiming at controlling the bacterial 
transmission and thus, prevent the spread of infection diseases were develop during the 
realization of this thesis. Different environment friendly strategies based on sonochemical or 
enzymatic techniques (avoiding the use of solvents and harsh chemicals), were adopted for 
the development of these materials. The designed nanocomposites share a common 
feature, namely high antibacterial performance against hospital relevant bacteria species. It 
was also demonstrated that the use of intrinsically antimicrobial polymers improves the 
nanocomposites durability at use, enhances their antibacterial performance and improves 
their biocompatibility.  
This thesis developed a platform of antibacterial materials and surfaces comprising: 
 
Antibacterial medical textiles via one-step sonochemical process: 
Simultaneous sonochemical coating of cotton with antibacterial zinc oxide/chitosan hybrid 
nanoparticles 
 The presence of chitosan in the hybrid biopolymer-metal oxide nanoparticles 
coatings generated on cotton fabrics improves the textiles antibacterial properties, 
durability of the antibacterial effect to washing, and biocompatibility (in comparison 
to zinc oxide nanoparticles coatings alone).  
 The synergistic effect of both chitosan and zinc oxide nanoparticles allowed for a 
high antibacterial performance of the hybrid coatings at minimum metal 
concentration.  
Simultaneous sono-enzymatic coating of cotton with antibacterial zinc oxide nanoparticles 
 Ultrasound-boosted enzymatic coating of cotton with zinc oxide nanoparticles 
improved the coating stability to washing and thus, ensure the fabric antibacterial 
properties. 
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Hybrid biopolymer-metal based nanoparticles and nanocomposites for water 
disinfection: 
 Permanent modification of the cork matrices is achieved via enzymatically grafting of 
amino-functionalized biopolymers (chitosan or aminocellulose) doped silver 
nanoparticles. 
 The biopolymers contributed to the antibacterial properties of the silver nanoparticles. 
 The antibacterial hybrid nanoparticles-cork composite demonstrated long-term stability 
and durability of the antimicrobial effect in conditions of continuous water flow. 
 
Hybrid nanocomposite hydrogels comprising of thiolated chitosan and 
epigallocatechin gallate nanospheres for wound healing applications.  
 
 Green approach involving the enzymatic cross-linking with horseradish peroxidase 
is accomplished for the formation biocompatible nanocomposite hydrogel. 
 The time of enzymatic gelation process is controllable through variation in the 
reagents’ concentrations. 
 Sustained delivery of intact phenolic nanospheres from the polymeric matrix is 
achieved.   
 The developed material showed potential to provide free of bacteria environment at 
the wound site while exhibiting control over the chronic wound enzymes activities. 
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7 Future perspectives 
 
 
 
 
 
 
 
 
 
 
 
 
 125 
 
  
 126 
 
Imparting antibacterial properties to the materials and surfaces is a key for achieving of 
bacteria-free environment in health care facilities and public areas. The results of this thesis 
have demonstrated that a wide variety of surface nanostructured 2D and 3D polymer-based 
materials for medical and industrial applications can be developed by applying an innovative 
combination of versatile sonochemical and enzymatic nano-coating technologies.  
The development of the antibacterial medical textiles (sections 5.1 and 5.2) was carried out 
under the scope of the large scale European project SONO - A pilot line of antibacterial and 
antifungal medical textiles based on a sonochemical process, FP7-228730, which was 
acknowledged as a “Success Story” by the European Commission. Within this project a pilot 
line for the production of medical antibacterial textiles based on the scale-up of the 
sonochemical coating process was developed. The antibacterial efficiency of the produced 
textiles, e.g. hospital sheets, medical coats and bandages was proven in a clinical trial 
carried out in the Multi-profile Hospital for Active Medical Treatment and Emergency 
Medicine "N.I.Pirogov" in Sofia, Bulgaria. In a further step, the sonochemical pilot will be 
brought to a pre-commercial level and demonstrated in relevant industrial environment for 
coating of antibacterial substrates such as medical textiles, upholstery, and water/air 
membranes among others. 
The disinfection efficacy of the developed at biopolymer/silver nanoparticles cork 
composites (section 5.3) will be evaluated at the level of a point-of-use water filtration device 
(water volume up to 2 L/day) prior constructing of larger disinfection installations e.g. point-
of-entry systems (disinfection capacity of 100 - 150 L water per day). In addition, the hybrid 
biopolymer/silver nanoparticles cork material can be used as disinfection element in already 
existing water purification systems as it is facile to manipulate.  
The efficiency of developed nanocomposite hydrogels (section 5.4) will be further tested ex 
vivo with real wound exudates and biofilms, prior to in vivo evaluation. In the production of 
nano-functionalized materials, nanotoxicology studies will ensure the safety of the workers, 
end users and the environment. 
A large number of applications can be foreseen based on the outcomes and the knowledge 
derived from this thesis. A variety of nano-sized actives can be generated via ultrasound 
irradiation e.g. nano-antibiotics, enzyme nano-particles, and hybrid nano-antibiotics, among 
others, and further incorporated, by employing different biotechnological approaches in 
polymer matrices to obtain antibacterial and antibiofilm materials.  
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